BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 2009;5:150-9. [PMID: 19229235 DOI: 10.1038/ncpendmet1066] [Cited by in Crossref: 363] [Cited by in F6Publishing: 388] [Article Influence: 27.9] [Reference Citation Analysis]
Number Citing Articles
1 Al-Sinani S, Al-Mamari A, Woodhouse N, Al-Shafie O, Amar F, Al-Shafaee M, Hassan M, Bayoumi R. Quality of diabetes care at outpatient clinic, sultan qaboos university hospital. Oman Med J 2015;30:48-54. [PMID: 25830001 DOI: 10.5001/omj.2015.09] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Acosta García EJ, Paez MC. Índice cardiometabólico como predictor de factores de riesgo cardiovascular en adolescentes. Rev salud pública 2018;20:340-5. [DOI: 10.15446/rsap.v20n3.61259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Jacobs S, Schiller K, Jansen EH, Boeing H, Schulze MB, Kröger J. Evaluation of various biomarkers as potential mediators of the association between Δ5 desaturase, Δ6 desaturase, and stearoyl-CoA desaturase activity and incident type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition-Potsdam Study. Am J Clin Nutr. 2015;102:155-164. [PMID: 25971719 DOI: 10.3945/ajcn.114.102707] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
4 Leiter LA, Cariou B, Müller-Wieland D, Colhoun HM, Del Prato S, Tinahones FJ, Ray KK, Bujas-Bobanovic M, Domenger C, Mandel J, Samuel R, Henry RR. Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM-INSULIN randomized trial. Diabetes Obes Metab 2017;19:1781-92. [PMID: 28905478 DOI: 10.1111/dom.13114] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 13.8] [Reference Citation Analysis]
5 Hamasaki H, Kawashima Y, Yanai H. Serum Zn/Cu Ratio Is Associated with Renal Function, Glycemic Control, and Metabolic Parameters in Japanese Patients with and without Type 2 Diabetes: A Cross-sectional Study. Front Endocrinol (Lausanne) 2016;7:147. [PMID: 27895622 DOI: 10.3389/fendo.2016.00147] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
6 Ward R, Hintze K. Fish and Fish Oil for Cardiovascular Disease in Diabetes. Fish and Fish Oil in Health and Disease Prevention. Elsevier; 2016. pp. 217-29. [DOI: 10.1016/b978-0-12-802844-5.00020-8] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Pan J, Ren Z, Li W, Wei Z, Rao H, Ren H, Zhang Z, Song W, He Y, Li C, Yang X, Chen L, Qiu L. Prevalence of hyperlipidemia in Shanxi Province, China and application of Bayesian networks to analyse its related factors. Sci Rep 2018;8:3750. [PMID: 29491353 DOI: 10.1038/s41598-018-22167-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
8 Biswas S, Zimman A, Gao D, Byzova TV, Podrez EA. TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated With Hyperlipidemia. Circ Res 2017;121:951-62. [PMID: 28775078 DOI: 10.1161/CIRCRESAHA.117.311069] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
9 Liu S, Qian Y, Lu F, Dong M, Lin Y, Li H, Shen C, Dai J, Jiang Y, Jin G, Hu Z, Shen H. Genetic variants at 10q23.33 are associated with plasma lipid levels in a Chinese population. J Biomed Res 2014;28:53-8. [PMID: 24474964 DOI: 10.7555/JBR.27.20120091] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Park JH, Jung H, Nam H, Kim J, Choe N, Suh J. Silk fibroin hydrolysate ameliorates diabetic dyslipidemia in type 2 diabetic model mice. Animal Cells and Systems 2013;17:325-30. [DOI: 10.1080/19768354.2013.839956] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
11 Baila-rueda L, Cenarro A, Lamiquiz-moneo I, Mateo-gallego R, Bea A, Perez-calahorra S, Marco-benedi V, Civeira F. Bile acid synthesis precursors in subjects with genetic hypercholesterolemia negative for LDLR/APOB/PCSK9/APOE mutations. Association with lipids and carotid atherosclerosis. The Journal of Steroid Biochemistry and Molecular Biology 2017;169:226-33. [DOI: 10.1016/j.jsbmb.2016.10.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Shatwan IA, Ahmed LA, Badkook MM. Effect of Barley Flour, Crude Cinnamon, and Their Combination on Glycemia, Dyslipidemia, and Adipose Tissue Hormones in Type 2 Diabetic Rats. Journal of Medicinal Food 2013;16:656-62. [DOI: 10.1089/jmf.2012.0083] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
13 Eken SM, Jin H, Chernogubova E, Maegdefessel L. Making sense in antisense: therapeutic potential of noncoding RNAs in diabetes-induced vascular dysfunction. J Diabetes Res 2013;2013:834727. [PMID: 24369540 DOI: 10.1155/2013/834727] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
14 Oloyede O, Ajiboye T, Abdussalam A, Adeleye A. Blighia sapida leaves halt elevated blood glucose, dyslipidemia and oxidative stress in alloxan-induced diabetic rats. Journal of Ethnopharmacology 2014;157:309-19. [DOI: 10.1016/j.jep.2014.08.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
15 Dagnew B, Yeshaw Y, Geremew D, Angaw DA, Dagne H, Alemayehu M, Molla MD, Akalu Y. Hypertriglyceridemia and Other Plasma Lipid Profile Abnormalities among People Living with Diabetes Mellitus in Ethiopia: A Systematic Review and Meta-Analysis. Biomed Res Int 2021;2021:7389076. [PMID: 34056001 DOI: 10.1155/2021/7389076] [Reference Citation Analysis]
16 Lorber D. Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes 2014;7:169-83. [PMID: 24920930 DOI: 10.2147/DMSO.S61438] [Cited by in Crossref: 99] [Cited by in F6Publishing: 49] [Article Influence: 12.4] [Reference Citation Analysis]
17 Wang P, Liu Y, Zhang T, Yin C, Kang SY, Kim SJ, Park YK, Jung HW. Effects of Root Extract of Morinda officinalis in Mice with High-Fat-Diet/Streptozotocin-Induced Diabetes and C2C12 Myoblast Differentiation. ACS Omega 2021;6:26959-68. [PMID: 34693116 DOI: 10.1021/acsomega.1c03372] [Reference Citation Analysis]
18 Cameron-Vendrig A, Mundil D, Husain M. Antiatherothrombotic effects of dipeptidyl peptidase inhibitors. Curr Atheroscler Rep 2014;16:408. [PMID: 24623180 DOI: 10.1007/s11883-014-0408-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Xia L, Cheng L, Jiang T, Liu C, Zhang S, Hu H, Dai F, Zhang Q, Lu Y. Estimation of the prevalence of type 2 diabetes in combination with diabetic kidney disease and identification of the associated factors in patients attending primary hospitals in Anhui Province, China. J Int Med Res 2021;49:3000605211051225. [PMID: 34670424 DOI: 10.1177/03000605211051225] [Reference Citation Analysis]
20 Erion DM, Park HJ, Lee HY. The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities. BMB Rep. 2016;49:139-148. [PMID: 26728273 DOI: 10.5483/bmbrep.2016.49.3.268] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 6.8] [Reference Citation Analysis]
21 Wasana KGP, Attanayake AP, Jayatilaka KAPW, Weerarathna TP. Antidiabetic Activity of Widely Used Medicinal Plants in the Sri Lankan Traditional Healthcare System: New Insight to Medicinal Flora in Sri Lanka. Evid Based Complement Alternat Med 2021;2021:6644004. [PMID: 33628307 DOI: 10.1155/2021/6644004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Moon S, Jang JY, Kim Y, Oh CM. Development and validation of a new diabetes index for the risk classification of present and new-onset diabetes: multicohort study. Sci Rep 2021;11:15748. [PMID: 34344964 DOI: 10.1038/s41598-021-95341-8] [Reference Citation Analysis]
23 Ha KH, Lee YH, Song SO, Lee JW, Kim DW, Cho KH, Kim DJ. Development and Validation of the Korean Diabetes Risk Score: A 10-Year National Cohort Study. Diabetes Metab J. 2018;42:402-414. [PMID: 30113144 DOI: 10.4093/dmj.2018.0014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
24 Lai L, Ghebremariam YT. Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin Sensitizers. J Diabetes Res 2016;2016:1982096. [PMID: 26770984 DOI: 10.1155/2016/1982096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
25 Oza MJ, Kulkarni YA. Biochanin A improves insulin sensitivity and controls hyperglycemia in type 2 diabetes. Biomed Pharmacother 2018;107:1119-27. [PMID: 30257324 DOI: 10.1016/j.biopha.2018.08.073] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
26 Pang J, Chan DC, Hamilton SJ, Tenneti VS, Watts GF, Barrett PHR. Effect of niacin on triglyceride-rich lipoprotein apolipoprotein B-48 kinetics in statin-treated patients with type 2 diabetes. Diabetes Obes Metab 2016;18:384-91. [DOI: 10.1111/dom.12622] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
27 Betanzos-cabrera G, Guerrero-solano J, Martínez-pérez M, Calderón-ramos Z, Belefant-miller H, Cancino-diaz J. Pomegranate juice increases levels of paraoxonase1 (PON1) expression and enzymatic activity in streptozotocin-induced diabetic mice fed with a high-fat diet. Food Research International 2011;44:1381-5. [DOI: 10.1016/j.foodres.2011.01.042] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
28 Roman-Urrestarazu A, Ali FM, Reka H, Renwick MJ, Roman GD, Mossialos E. Structural equation model for estimating risk factors in type 2 diabetes mellitus in a Middle Eastern setting: evidence from the STEPS Qatar. BMJ Open Diabetes Res Care 2016;4:e000231. [PMID: 27752326 DOI: 10.1136/bmjdrc-2016-000231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
29 Magaye RR, Savira F, Hua Y, Kelly DJ, Reid C, Flynn B, Liew D, Wang BH. The role of dihydrosphingolipids in disease. Cell Mol Life Sci 2019;76:1107-34. [PMID: 30523364 DOI: 10.1007/s00018-018-2984-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
30 Al Sayed N, Al Waili K, Alawadi F, Al-Ghamdi S, Al Mahmeed W, Al-Nouri F, Al Rukhaimi M, Al-Rasadi K, Awan Z, Farghaly M, Hassanein M, Sabbour H, Zubaid M, Barter P. Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East. Int J Cardiol 2016;225:268-83. [PMID: 27741487 DOI: 10.1016/j.ijcard.2016.09.081] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
31 Cheon HG, Cho YS. Protection of palmitic acid-mediated lipotoxicity by arachidonic acid via channeling of palmitic acid into triglycerides in C2C12. J Biomed Sci 2014;21:13. [PMID: 24521082 DOI: 10.1186/1423-0127-21-13] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
32 Li D, Zhang Y, Liu Y, Sun R, Xia M. Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients. J Nutr 2015;145:742-8. [PMID: 25833778 DOI: 10.3945/jn.114.205674] [Cited by in Crossref: 141] [Cited by in F6Publishing: 114] [Article Influence: 20.1] [Reference Citation Analysis]
33 Karimi E, Sotoudeh G, Rafiee M, Koohdani F. Dietary quality indices modify the effects of apolipoprotein B polymorphisms on biochemical and anthropometric factors in type 2 diabetes mellitus. Sci Rep 2021;11:22395. [PMID: 34789800 DOI: 10.1038/s41598-021-01884-1] [Reference Citation Analysis]
34 Haidari F, Zakerkish M, Borazjani F, Ahmadi Angali K, Amoochi Foroushani G. The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes. Trials 2020;21:483. [PMID: 32503652 DOI: 10.1186/s13063-020-04401-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Rendina-Ruedy E, Rosen CJ. Lipids in the Bone Marrow: An Evolving Perspective. Cell Metab 2020;31:219-31. [PMID: 31668874 DOI: 10.1016/j.cmet.2019.09.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
36 Gómez-Hernández A, Beneit N, Díaz-Castroverde S, Escribano Ó. Differential Role of Adipose Tissues in Obesity and Related Metabolic and Vascular Complications. Int J Endocrinol 2016;2016:1216783. [PMID: 27766104 DOI: 10.1155/2016/1216783] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 12.5] [Reference Citation Analysis]
37 Bai H, Liu H, Suyalatu S, Guo X, Chu S, Chen Y, Lan T, Borjigin B, Orlov YL, Posukh OL, Yang X, Guilan G, Osipova LP, Wu Q, Narisu N. Association Analysis of Genetic Variants with Type 2 Diabetes in a Mongolian Population in China. J Diabetes Res 2015;2015:613236. [PMID: 26290879 DOI: 10.1155/2015/613236] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
38 Bianchetti G, Di Giacinto F, Pitocco D, Rizzi A, Rizzo GE, De Leva F, Flex A, di Stasio E, Ciasca G, De Spirito M, Maulucci G. Red blood cells membrane micropolarity as a novel diagnostic indicator of type 1 and type 2 diabetes. Anal Chim Acta X 2019;3:100030. [PMID: 33117983 DOI: 10.1016/j.acax.2019.100030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
39 Ali F, Jamil H, Anwar SS, Wajid N. Characterization of lipid parameters in diabetic and non-diabetic atherosclerotic patients. J Geriatr Cardiol 2015;12:37-43. [PMID: 25678903 DOI: 10.11909/j.issn.1671-5411.2015.01.005] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
40 Kountz D. Special considerations of care and risk management for African American patients with type 2 diabetes mellitus. J Natl Med Assoc 2012;104:265-73. [PMID: 22973676 DOI: 10.1016/s0027-9684(15)30158-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
41 Cochran BJ, Ong KL, Manandhar B, Rye KA. High Density Lipoproteins and Diabetes. Cells 2021;10:850. [PMID: 33918571 DOI: 10.3390/cells10040850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Vaverkova H, Farnier M, Averna M, Missault L, Viigimaa M, Dong Q, Shah A, Johnson-levonas AO, Brudi P. Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20 mg Compared to Rosuvastatin 10 mg in High-Risk Patients with and without Type 2 Diabetes Mellitus Inadequately Controlled Despite Prior Statin Monotherapy: Subgroup Evaluation of Ezetimibe/Simvastatin Versus Rosuvastatin. Cardiovascular Therapeutics 2012;30:61-74. [DOI: 10.1111/j.1755-5922.2010.00181.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
43 Zuin M, Rigatelli G, L'Erario R, Zuliani G, Bilato C, Roncon L. Herpes zoster infection and statins: which implications in clinical practice? Eur J Clin Microbiol Infect Dis 2019;38:93-9. [PMID: 30298219 DOI: 10.1007/s10096-018-3399-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 Zhu L, Hayen A, Bell KJL. Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study. Cardiovasc Diabetol 2020;19:28. [PMID: 32138746 DOI: 10.1186/s12933-020-01002-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
45 Mahapatra DK, Asati V, Bharti SK. Chalcones and their therapeutic targets for the management of diabetes: structural and pharmacological perspectives. Eur J Med Chem 2015;92:839-65. [PMID: 25638569 DOI: 10.1016/j.ejmech.2015.01.051] [Cited by in Crossref: 130] [Cited by in F6Publishing: 90] [Article Influence: 18.6] [Reference Citation Analysis]
46 Ashwini S, Bobby Z, Joseph M. Mild hypothyroidism improves glucose tolerance in experimental type 2 diabetes. Chemico-Biological Interactions 2015;235:47-55. [DOI: 10.1016/j.cbi.2015.04.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
47 Luo J, Jiang B, Li C, Jia X, Shi D. CYC27 Synthetic Derivative of Bromophenol from Red Alga Rhodomela confervoides: Anti-Diabetic Effects of Sensitizing Insulin Signaling Pathways and Modulating RNA Splicing-Associated RBPs. Mar Drugs 2019;17:E49. [PMID: 30641913 DOI: 10.3390/md17010049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
48 Tang X, Olatunji OJ, Zhou Y, Hou X. Allium tuberosum: Antidiabetic and hepatoprotective activities. Food Res Int 2017;102:681-9. [PMID: 29196001 DOI: 10.1016/j.foodres.2017.08.034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
49 Singh S, Verma N, Karwasra R, Kalra P, Kumar R, Gupta YK. Safety and efficacy of hydroalcoholic extract from Lawsonia inermis leaves on lipid profile in alloxan-induced diabetic rats. Ayu 2015;36:107-12. [PMID: 26730149 DOI: 10.4103/0974-8520.168999] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
50 Xu DM, Li Q, Yi JX, Cai XJ, Xie L, Fang W, Qiu JF, Xu CW, He CL, Xu XR, Xu JS, Yin J. Investigation of Lymphocyte Subsets in Peripheral Blood of Patients with Dyslipidemia. Int J Gen Med 2021;14:5573-9. [PMID: 34548808 DOI: 10.2147/IJGM.S326628] [Reference Citation Analysis]
51 Abou Zeid OA, Elkhouly NY, Osman EN, Youssef MH. Metabolic parameters in diabetic neuropathic patients after treatment with pregabalin. Diabetes Metab Syndr 2017;11 Suppl 1:S263-72. [PMID: 28041922 DOI: 10.1016/j.dsx.2016.12.042] [Reference Citation Analysis]
52 Harcourt BE, Penfold SA, Forbes JM. Coming full circle in diabetes mellitus: from complications to initiation. Nat Rev Endocrinol 2013;9:113-23. [PMID: 23296171 DOI: 10.1038/nrendo.2012.236] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
53 Shi L, Hu J, Zhu K, Fu Y, Xia R, Hu X. Changes of prevalence of dyslipidemia among adults: a cross-sectional study with a 2-year follow-up in urban southeast China. Clinical Lipidology 2014;9:33-47. [DOI: 10.2217/clp.13.82] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
54 Kawanami D, Matoba K, Utsunomiya K. Dyslipidemia in diabetic nephropathy. Ren Replace Ther 2016;2. [DOI: 10.1186/s41100-016-0028-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
55 Johnson LA, Maeda N. Macrovascular complications of diabetes in atherosclerosisprone mice. Expert Rev Endocrinol Metab 2010;5:89-98. [PMID: 30934383 DOI: 10.1586/eem.09.66] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Brady RP, Shah AS, Jensen ET, Stafford JM, D'Agostino RB Jr, Dolan LM, Knight L, Imperatore G, Turley CB, Liese AD, Urbina EM, Lawrence JM, Pihoker C, Marcovina S, Dabelea D. Glycemic control is associated with dyslipidemia over time in youth with type 2 diabetes: The SEARCH for diabetes in youth study. Pediatr Diabetes 2021. [PMID: 34363298 DOI: 10.1111/pedi.13253] [Reference Citation Analysis]
57 Ofori EK, Owusu-Ababio D, Tagoe EA, Asare-Anane H. Dyslipidaemia is common among patients with type 2 diabetes: a cross-sectional study at Tema Port Clinic. BMC Res Notes 2019;12:204. [PMID: 30944035 DOI: 10.1186/s13104-019-4245-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
58 Zhang H, Xu Z, Zhao H, Wang X, Pang J, Li Q, Yang Y, Ling W. Anthocyanin supplementation improves anti-oxidative and anti-inflammatory capacity in a dose-response manner in subjects with dyslipidemia. Redox Biol 2020;32:101474. [PMID: 32179241 DOI: 10.1016/j.redox.2020.101474] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
59 Acharya P, Uppin V, Zarei M, Talahalli RR. Role of n-3 Fatty Acids on Bile Acid Metabolism and Transport in Dyslipidemia: A Review. Lipids 2021;56:125-39. [PMID: 33074554 DOI: 10.1002/lipd.12289] [Reference Citation Analysis]
60 Wakabayashi I. Associations of Smoking and Drinking with New Lipid-Related Indices in Women with Hyperglycemia. Womens Health Rep (New Rochelle) 2021;2:23-31. [PMID: 33786527 DOI: 10.1089/whr.2020.0100] [Reference Citation Analysis]
61 Basile JN. A Multifactorial Approach to Reduce Cardiovascular Disease in Type 2 Diabetes Mellitus: Now More Than Ever. Hosp Pract (1995) 2016;44:9-20. [PMID: 26781810 DOI: 10.1080/21548331.2016.1141656] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Wang SY, Hsieh MC, Tu ST, Chuang CS. New frontiers in the treatment of diabetic dyslipidemia. Rev Diabet Stud 2013;10:204-12. [PMID: 24380093 DOI: 10.1900/RDS.2013.10.204] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
63 Tekwe CD, Carter RL, Cullings HM, Carroll RJ. Multiple indicators, multiple causes measurement error models. Stat Med 2014;33:4469-81. [PMID: 24962535 DOI: 10.1002/sim.6243] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
64 Cao JY, Waldman B, O'Connell R, Sullivan DR, Scott RS, Aryal N, Gebski V, Marschner I, Taskinen MR, Simes JR, McGill N, Jenkins AJ, Keech AC; FIELD investigators. Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study. Diabetes Obes Metab 2020;22:1388-96. [PMID: 32243036 DOI: 10.1111/dom.14046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Elissa LA, Elsherbiny NM, Magmomah AO. Propolis restored adiponectin level in type 2 diabetes through PPARγ activation. Egyptian Journal of Basic and Applied Sciences 2019;2:318-26. [DOI: 10.1016/j.ejbas.2015.06.003] [Cited by in Crossref: 7] [Article Influence: 2.3] [Reference Citation Analysis]
66 El Agaty SM. Cardioprotective effect of vitamin D 2 on isoproterenol-induced myocardial infarction in diabetic rats*. Archives of Physiology and Biochemistry 2018;125:210-9. [DOI: 10.1080/13813455.2018.1448423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
67 Cuevas M. A, Alonso K R. DISLIPIDEMIA DIABÉTICA. Revista Médica Clínica Las Condes 2016;27:152-9. [DOI: 10.1016/j.rmclc.2016.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Guo H, Cao A, Chu S, Wang Y, Zang Y, Mao X, Wang H, Wang Y, Liu C, Zhang X, Peng W. Astragaloside IV Attenuates Podocyte Apoptosis Mediated by Endoplasmic Reticulum Stress through Upregulating Sarco/Endoplasmic Reticulum Ca2+-ATPase 2 Expression in Diabetic Nephropathy. Front Pharmacol 2016;7:500. [PMID: 28066247 DOI: 10.3389/fphar.2016.00500] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
69 Biadgo B, Abebe SM, Baynes HW, Yesuf M, Alemu A, Abebe M. Correlation between Serum Lipid Profile with Anthropometric and Clinical Variables in Patients with Type 2 Diabetes Mellitus. Ethiop J Health Sci 2017;27:215-26. [PMID: 29217920 DOI: 10.4314/ejhs.v27i3.3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
70 Lapmanee S, Charoenphandhu N, Aeimlapa R, Suntornsaratoon P, Wongdee K, Tiyasatkulkovit W, Kengkoom K, Chaimongkolnukul K, Seriwatanachai D, Krishnamra N. High dietary cholesterol masks type 2 diabetes-induced osteopenia and changes in bone microstructure in rats. Lipids 2014;49:975-86. [PMID: 25200330 DOI: 10.1007/s11745-014-3950-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
71 Taskinen MR, Barter PJ, Ehnholm C, Sullivan DR, Mann K, Simes J, Best JD, Hamwood S, Keech AC. Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes. Diabetologia. 2010;53:1846-1855. [PMID: 20526762 DOI: 10.1007/s00125-010-1806-9] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
72 Bartelt A, Bruns OT, Reimer R, Hohenberg H, Ittrich H, Peldschus K, Kaul MG, Tromsdorf UI, Weller H, Waurisch C. Brown adipose tissue activity controls triglyceride clearance. Nat Med. 2011;17:200-205. [PMID: 21258337 DOI: 10.1038/nm.2297] [Cited by in Crossref: 1017] [Cited by in F6Publishing: 948] [Article Influence: 92.5] [Reference Citation Analysis]
73 Warraich HJ, Wong ND, Rana JS. Role for Combination Therapy in Diabetic Dyslipidemia. Curr Cardiol Rep 2015;17. [DOI: 10.1007/s11886-015-0589-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
74 Makinde EA, Radenahmad N, Adekoya AE, Olatunji OJ. Tiliacora triandra extract possesses antidiabetic effects in high fat diet/streptozotocin-induced diabetes in rats. J Food Biochem 2020;44:e13239. [PMID: 32281660 DOI: 10.1111/jfbc.13239] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
75 Ganasegeran K, Renganathan P, Manaf RA, Al-Dubai SA. Factors associated with anxiety and depression among type 2 diabetes outpatients in Malaysia: a descriptive cross-sectional single-centre study. BMJ Open 2014;4:e004794. [PMID: 24760351 DOI: 10.1136/bmjopen-2014-004794] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
76 Zhu K, Nie S, Li C, Lin S, Xing M, Li W, Gong D, Xie M. A newly identified polysaccharide from Ganoderma atrum attenuates hyperglycemia and hyperlipidemia. International Journal of Biological Macromolecules 2013;57:142-50. [DOI: 10.1016/j.ijbiomac.2013.03.009] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 7.1] [Reference Citation Analysis]
77 Scifres CM, Chen B, Nelson DM, Sadovsky Y. Fatty acid binding protein 4 regulates intracellular lipid accumulation in human trophoblasts. J Clin Endocrinol Metab 2011;96:E1083-91. [PMID: 21525163 DOI: 10.1210/jc.2010-2084] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 6.9] [Reference Citation Analysis]
78 Wang J, Huang C, Hung Y, Kwok C, Sun J, Pei D, Yang C, Chen C, Lin C, Sheu WH. Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes. Diabetes Research and Clinical Practice 2013;102:16-24. [DOI: 10.1016/j.diabres.2013.08.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
79 Tetik Vardarlı A, Harman E, Bozok Çetintaş V, Kayıkçıoğlu M, Vardarlı E, Zengi A, Küçükaslan AŞ, Eroğlu Z. Polymorphisms of lipid metabolism enzyme-coding genes in patients with diabetic dyslipidemia. Anatol J Cardiol 2017;17:313-21. [PMID: 28315561 DOI: 10.14744/AnatolJCardiol.2016.7142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
80 Shui G, Lam SM, Stebbins J, Kusunoki J, Duan X, Li B, Cheong WF, Soon D, Kelly RP, Wenk MR. Polar lipid derangements in type 2 diabetes mellitus: potential pathological relevance of fatty acyl heterogeneity in sphingolipids. Metabolomics 2013;9:786-99. [DOI: 10.1007/s11306-013-0494-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
81 Warraich HJ, Rana JS. Dyslipidemia in diabetes mellitus and cardiovascular disease. Cardiovasc Endocrinol 2017;6:27-32. [PMID: 31646116 DOI: 10.1097/XCE.0000000000000120] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
82 Zhang R, Abou-Samra AB. A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy. Cardiovasc Diabetol 2014;13:133. [PMID: 25212743 DOI: 10.1186/s12933-014-0133-8] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 8.0] [Reference Citation Analysis]
83 Akhavan NS, Pourafshar S, Johnson SA, Foley EM, George KS, Munoz J, Siebert S, Clark EA, Basiri R, Hickner RC, Navaei N, Levenson CW, Panton LB, Daggy BP, Arjmandi BH. The Relationship between Protein Intake and Source on Factors Associated with Glycemic Control in Individuals with Prediabetes and Type 2 Diabetes. Nutrients 2020;12:E2031. [PMID: 32650580 DOI: 10.3390/nu12072031] [Reference Citation Analysis]
84 Mangat R, Borthwick F, Haase T, Jacome M, Nelson R, Kontush A, Vine DF, Proctor SD. Intestinal lymphatic HDL miR‐223 and ApoA‐I are reduced during insulin resistance and restored with niacin. FASEB j 2018;32:1602-12. [DOI: 10.1096/fj.201600298rr] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
85 Mellitzer G, Gradwohl G. Enteroendocrine cells and lipid absorption: . Current Opinion in Lipidology 2011;22:171-5. [DOI: 10.1097/mol.0b013e32834622a2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
86 Wakabayashi I. Smoking and lipid-related indices in patients with diabetes mellitus. Diabet Med 2014;31:868-78. [PMID: 24606550 DOI: 10.1111/dme.12430] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
87 Adeyanju OA, Soetan OA, Soladoye AO, Olatunji LA. Oral hormonal therapy with ethinylestradiol–levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating mineralocorticoid in estrogen-deficient rats. Can J Physiol Pharmacol 2018;96:577-86. [DOI: 10.1139/cjpp-2017-0630] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
88 Aliyari R, Hajizadeh E, Aminorroaya A, Sharifi F, Kazemi I, Baghestani AR. Multistate Models to Predict Development of Late Complications of Type 2 Diabetes in an Open Cohort Study. Diabetes Metab Syndr Obes 2020;13:1863-72. [PMID: 32547148 DOI: 10.2147/DMSO.S234563] [Reference Citation Analysis]
89 Shokoohi R, Kianbakht S, Faramarzi M, Rahmanian M, Nabati F, Mehrzadi S, Huseini HF. Effects of an Herbal Combination on Glycemic Control and Lipid Profile in Diabetic Women: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Evid Based Complementary Altern Med 2017;22:798-804. [PMID: 29228822 DOI: 10.1177/2156587217737683] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
90 Bhute SS, Suryavanshi MV, Joshi SM, Yajnik CS, Shouche YS, Ghaskadbi SS. Gut Microbial Diversity Assessment of Indian Type-2-Diabetics Reveals Alterations in Eubacteria, Archaea, and Eukaryotes. Front Microbiol. 2017;8:214. [PMID: 28261173 DOI: 10.3389/fmicb.2017.00214] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
91 Haas ME, Attie AD, Biddinger SB. The regulation of ApoB metabolism by insulin. Trends Endocrinol Metab 2013;24:391-7. [PMID: 23721961 DOI: 10.1016/j.tem.2013.04.001] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 7.7] [Reference Citation Analysis]
92 Barter PJ. The causes and consequences of low levels of high density lipoproteins in patients with diabetes. Diabetes Metab J 2011;35:101-6. [PMID: 21738891 DOI: 10.4093/dmj.2011.35.2.101] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
93 Engwa GA, Nwalo FN, Chiezey VO, Unachukwu MN, Ojo OO, Ubi BE. Assessment of the Pro12Ala Polymorphism in the PPAR-γ2 Gene among Type 2 Diabetes Patients in a Nigerian Population. J Clin Med 2018;7:E69. [PMID: 29621178 DOI: 10.3390/jcm7040069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
94 Schwenke DC, Foreyt JP, Miller ER 3rd, Reeves RS, Vitolins MZ; Oxidative Stress Subgroup of the Look AHEAD Research Group. Plasma concentrations of trans fatty acids in persons with type 2 diabetes between September 2002 and April 2004. Am J Clin Nutr 2013;97:862-71. [PMID: 23446895 DOI: 10.3945/ajcn.112.046508] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
95 Bonilha I, Hajduch E, Luchiari B, Nadruz W, Le Goff W, Sposito AC. The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus. Metabolites 2021;11:807. [PMID: 34940565 DOI: 10.3390/metabo11120807] [Reference Citation Analysis]
96 Kim JI, Yun JA, Jeong YK, Baek HJ. Hypoglycemic and hypolipidemic effects of samnamul (shoot of Aruncus dioicus var. kamtschaticus Hara) in mice fed a high-fat/high-sucrose diet. Food Sci Biotechnol 2018;27:1467-73. [PMID: 30319857 DOI: 10.1007/s10068-018-0390-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
97 Shankar K, Singh SK, Kumar D, Varshney S, Gupta A, Rajan S, Srivastava A, Beg M, Srivastava AK, Kanojiya S, Mishra DK, Gaikwad AN. Cucumis melo ssp. Agrestis var. Agrestis Ameliorates High Fat Diet Induced Dyslipidemia in Syrian Golden Hamsters and Inhibits Adipogenesis in 3T3-L1 Adipocytes. Pharmacogn Mag 2015;11:S501-10. [PMID: 27013786 DOI: 10.4103/0973-1296.172945] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
98 Savolainen MJ. Epidemiology: Disease Associations and Modulators of HDL-Related Biomarkers. In: von Eckardstein A, Kardassis D, editors. High Density Lipoproteins. Cham: Springer International Publishing; 2015. pp. 259-83. [DOI: 10.1007/978-3-319-09665-0_7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
99 Du Q, Qian MM, Liu PL, Zhang L, Wang Y, Liu DH. Glycation of high-density lipoprotein triggers oxidative stress and promotes the proliferation and migration of vascular smooth muscle cells. J Geriatr Cardiol 2017;14:473-80. [PMID: 28868076 DOI: 10.11909/j.issn.1671-5411.2017.07.003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
100 Gong S, Xu C, Wang L, Liu Y, Owusu D, Bailey BA, Li Y, Wang K. Genetic association analysis of polymorphisms in PSD3 gene with obesity, type 2 diabetes, and HDL cholesterol. Diabetes Research and Clinical Practice 2017;126:105-14. [DOI: 10.1016/j.diabres.2017.02.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
101 Yoon SR, Lee JH, Na GY, Seo YJ, Han S, Shin MJ, Kim OY. Glycated Hemoglobin is a Better Predictor than Fasting Glucose for Cardiometabolic Risk in Non-diabetic Korean Women. Clin Nutr Res 2015;4:97-103. [PMID: 25954730 DOI: 10.7762/cnr.2015.4.2.97] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
102 Preetha PP, Devi VG, Rajamohan T. Antihyperlipidemic effects of mature coconut water and its role in regulating lipid metabolism in alloxan-induced experimental diabetes. Comp Clin Pathol 2014;23:1331-7. [DOI: 10.1007/s00580-013-1784-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
103 Calkin C, McClelland C, Cairns K, Kamintsky L, Friedman A. Insulin Resistance and Blood-Brain Barrier Dysfunction Underlie Neuroprogression in Bipolar Disorder. Front Psychiatry 2021;12:636174. [PMID: 34113269 DOI: 10.3389/fpsyt.2021.636174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Kumawat VS, Kaur G. Insulinotropic and antidiabetic effects of β-caryophyllene with l-arginine in type 2 diabetic rats. J Food Biochem 2020;44:e13156. [PMID: 31997410 DOI: 10.1111/jfbc.13156] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
105 Sekar R, Chow BK. Lipolytic actions of secretin in mouse adipocytes. J Lipid Res 2014;55:190-200. [PMID: 24273196 DOI: 10.1194/jlr.M038042] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
106 Ozder A. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study. Lipids Health Dis 2014;13:183. [PMID: 25481115 DOI: 10.1186/1476-511X-13-183] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
107 Bays HE. Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus. Int J Gen Med 2014;7:355-64. [PMID: 25045281 DOI: 10.2147/IJGM.S65148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
108 Barr MM, Aslibekyan S, Ashraf AP. Glycemic control and lipid outcomes in children and adolescents with type 2 diabetes. PLoS One 2019;14:e0219144. [PMID: 31260475 DOI: 10.1371/journal.pone.0219144] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
109 Bekele S, Yohannes T, Mohammed AE. Dyslipidemia and associated factors among diabetic patients attending Durame General Hospital in Southern Nations, Nationalities, and People's Region. Diabetes Metab Syndr Obes 2017;10:265-71. [PMID: 28790859 DOI: 10.2147/DMSO.S135064] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
110 Sánchez-quesada JL, Pérez A. Lipoproteínas modificadas como marcadores de riesgo cardiovascular en la diabetes mellitus. Endocrinología y Nutrición 2013;60:518-28. [DOI: 10.1016/j.endonu.2012.12.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
111 Peng S, Wei P, Lu Q, Liu R, Ding Y, Zhang J. Beneficial Effects of Poplar Buds on Hyperglycemia, Dyslipidemia, Oxidative Stress, and Inflammation in Streptozotocin-Induced Type-2 Diabetes. J Immunol Res 2018;2018:7245956. [PMID: 30320140 DOI: 10.1155/2018/7245956] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
112 Sone H, Tanaka S, Tanaka S, Iimuro S, Ishibashi S, Oikawa S, Shimano H, Katayama S, Ohashi Y, Akanuma Y, Yamada N; Japan Diabetes Complications Study Group. Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study. Diabetes Care 2012;35:1150-7. [PMID: 22338107 DOI: 10.2337/dc11-1412] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
113 Müller-Wieland D, Leiter LA, Cariou B, Letierce A, Colhoun HM, Del Prato S, Henry RR, Tinahones FJ, Aurand L, Maroni J, Ray KK, Bujas-Bobanovic M. Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk. Cardiovasc Diabetol 2017;16:70. [PMID: 28545518 DOI: 10.1186/s12933-017-0552-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
114 Tareke AA, Hadgu AA. The effect of vitamin C supplementation on lipid profile of type 2 diabetic patients: a systematic review and meta-analysis of clinical trials. Diabetol Metab Syndr 2021;13:24. [PMID: 33653396 DOI: 10.1186/s13098-021-00640-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
115 Kowluru RA. Retinopathy in a Diet-Induced Type 2 Diabetic Rat Model and Role of Epigenetic Modifications. Diabetes 2020;69:689-98. [PMID: 31949005 DOI: 10.2337/db19-1009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
116 Leiter LA, Betteridge DJ, Farnier M, Guyton JR, Lin J, Shah A, Johnson-levonas AO, Brudi P. Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials. Diabetes, Obesity and Metabolism 2011;13:615-28. [DOI: 10.1111/j.1463-1326.2011.01383.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
117 Bhowmik B, Siddiquee T, Mujumder A, Afsana F, Ahmed T, Mdala IA, do V Moreira NC, Khan AKA, Hussain A, Holmboe-Ottesen G, Omsland TK. Serum Lipid Profile and Its Association with Diabetes and Prediabetes in a Rural Bangladeshi Population. Int J Environ Res Public Health 2018;15:E1944. [PMID: 30200612 DOI: 10.3390/ijerph15091944] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
118 Villeneuve LM, Natarajan R. Epigenetics of diabetic complications. Expert Rev Endocrinol Metab 2010;5:137-48. [PMID: 24077653 DOI: 10.1586/eem.09.54] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
119 Jacobs S, Kröger J, Floegel A, Boeing H, Drogan D, Pischon T, Fritsche A, Prehn C, Adamski J, Isermann B, Weikert C, Schulze MB. Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study. The American Journal of Clinical Nutrition 2014;100:891-900. [DOI: 10.3945/ajcn.113.080317] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 6.5] [Reference Citation Analysis]
120 Suhre K, Meisinger C, Döring A, Altmaier E, Belcredi P, Gieger C, Chang D, Milburn MV, Gall WE, Weinberger KM, Mewes HW, Hrabé de Angelis M, Wichmann HE, Kronenberg F, Adamski J, Illig T. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One 2010;5:e13953. [PMID: 21085649 DOI: 10.1371/journal.pone.0013953] [Cited by in Crossref: 407] [Cited by in F6Publishing: 362] [Article Influence: 33.9] [Reference Citation Analysis]
121 Kimura Y, Tamasawa N, Matsumura K, Murakami H, Yamashita M, Matsuki K, Tanabe J, Murakami H, Matsui J, Daimon M. Clinical Significance of Determining Plasma MicroRNA33b in Type 2 Diabetic Patients with Dyslipidemia. J Atheroscler Thromb 2016;23:1276-85. [PMID: 27301461 DOI: 10.5551/jat.33670] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
122 Liu X, Wu Z, Lian J, Hu CH, Huang XF, Deng C. Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats. Sci Rep 2017;7:2762. [PMID: 28584269 DOI: 10.1038/s41598-017-02884-w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
123 Nikpayam O, Faghfouri AH, Tavakoli-rouzbehani OM, Jalali S, Najafi M, Sohrab G. The effect of green coffee extract supplementation on lipid profile: A systematic review of clinical trial and in-vivo studies. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020;14:1521-8. [DOI: 10.1016/j.dsx.2020.07.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
124 Eroglu Z, Harman E, Vardarli E, Kayikcioglu M, Vardarli AT. LDLR C1725T Gene Polymorphism Frequency in Type 2 Diabetes Mellitus Patients With Dyslipidemia. J Clin Med Res 2016;8:793-6. [PMID: 27738480 DOI: 10.14740/jocmr2739w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
125 Yamazaki RK, Brito GA, Coelho I, Pequitto DC, Yamaguchi AA, Borghetti G, Schiessel DL, Kryczyk M, Machado J, Rocha RE, Aikawa J, Iagher F, Naliwaiko K, Tanhoffer RA, Nunes EA, Fernandes LC. Low fish oil intake improves insulin sensitivity, lipid profile and muscle metabolism on insulin resistant MSG-obese rats. Lipids Health Dis 2011;10:66. [PMID: 21526994 DOI: 10.1186/1476-511X-10-66] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
126 Pandey A, Chawla S, Guchhait P. Type-2 diabetes: Current understanding and future perspectives. IUBMB Life 2015;67:506-13. [PMID: 26177573 DOI: 10.1002/iub.1396] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 6.9] [Reference Citation Analysis]
127 Xie X, Gao H, Wu S, Zhao Y, Du C, Yuan G, Ning Q, McCormick K, Luo X. Increased Cord Blood Betatrophin Levels in the Offspring of Mothers with Gestational Diabetes. PLoS One 2016;11:e0155646. [PMID: 27196053 DOI: 10.1371/journal.pone.0155646] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
128 Chai BK, Lau YS, Loong BJ, Rais MM, Ting KN, Dharmani DM, Mohankumar SK. Co-administration of conjugated linoleic acid and rosiglitazone increases atherogenic co-efficient and alters isoprenaline-induced vasodilatation in rats fed high fat diet. Physiol Res 2018;67:729-40. [PMID: 29750886 DOI: 10.33549/physiolres.933706] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
129 Sadeghi E, Hosseini SM, Vossoughi M, Aminorroaya A, Amini M. Association of Lipid Profile with Type 2 Diabetes in First-Degree Relatives: A 14-Year Follow-Up Study in Iran. Diabetes Metab Syndr Obes 2020;13:2743-50. [PMID: 32801820 DOI: 10.2147/DMSO.S259697] [Reference Citation Analysis]
130 Sun Y, Ma C, Sun H, Wang H, Peng W, Zhou Z, Wang H, Pi C, Shi Y, He X. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease. J Diabetes Res 2020;2020:4981814. [PMID: 32083135 DOI: 10.1155/2020/4981814] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
131 Tadewos A, Egeno T, Amsalu A. Risk factors of metabolic syndrome among hypertensive patients at Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia. BMC Cardiovasc Disord 2017;17:218. [PMID: 28789613 DOI: 10.1186/s12872-017-0648-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
132 Tong X, Peng H, Liu D, Ji L, Niu C, Ren J, Pan B, Hu J, Zheng L, Huang Y. High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate. Cardiovasc Diabetol 2013;12:27. [PMID: 23360427 DOI: 10.1186/1475-2840-12-27] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
133 Hassan F, El-said EE, El-sayed GR, El-sayed SAE, Awadin WF. Vitamin D dietary supplementation ameliorates the complications associated with type 2 diabetes induced by streptozotocin. Comp Clin Pathol 2020;29:591-8. [DOI: 10.1007/s00580-020-03093-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Zeng P, Wang T, Zheng J, Zhou X. Causal association of type 2 diabetes with amyotrophic lateral sclerosis: new evidence from Mendelian randomization using GWAS summary statistics. BMC Med 2019;17:225. [PMID: 31796040 DOI: 10.1186/s12916-019-1448-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
135 Tian J, Chen H, Jia F, Yang G, Li S, Li K, Zhang L, Wu J, Liu D. Trends in the Levels of Serum Lipids and Lipoproteins and the Prevalence of Dyslipidemia in Adults with Newly Diagnosed Type 2 Diabetes in the Southwest Chinese Han Population during 2003-2012. Int J Endocrinol 2015;2015:818075. [PMID: 26089896 DOI: 10.1155/2015/818075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
136 Esteghamati A, Zandieh A, Zandieh B, Khalilzadeh O, Esteghamati S, Meysamie A, Nakhjavani M. Comparing abilities of different lipid measures in diagnosis of insulin resistance: a Survey of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) study. Metab Syndr Relat Disord 2012;10:63-9. [PMID: 22010642 DOI: 10.1089/met.2011.0002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
137 Shantakumari N, Sequeira S, El deeb R. Effects of a yoga intervention on lipid profiles of diabetes patients with dyslipidemia. Indian Heart J 2013;65:127-31. [PMID: 23647889 DOI: 10.1016/j.ihj.2013.02.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
138 Balbaa M, El-Zeftawy M, Ghareeb D, Taha N, Mandour AW. Nigella sativa Relieves the Altered Insulin Receptor Signaling in Streptozotocin-Induced Diabetic Rats Fed with a High-Fat Diet. Oxid Med Cell Longev 2016;2016:2492107. [PMID: 27579151 DOI: 10.1155/2016/2492107] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
139 Nayak SB, Mohammed SB, Nayak AS. Controlling Lipids AIDS in the Prevention of Type 2 Diabetes, Hypertension, and Cardiovascular Diseases. Int J Prev Med 2017;8:39. [PMID: 28656095 DOI: 10.4103/ijpvm.IJPVM_184_16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
140 Masana L, Cabré A, Heras M, Amigó N, Correig X, Martínez-Hervás S, Real JT, Ascaso JF, Quesada H, Julve J, Palomer X, Vázquez-Carrera M, Girona J, Plana N, Blanco-Vaca F. Remarkable quantitative and qualitative differences in HDL after niacin or fenofibrate therapy in type 2 diabetic patients. Atherosclerosis 2015;238:213-9. [PMID: 25528430 DOI: 10.1016/j.atherosclerosis.2014.12.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
141 Corbi SCT, Bastos AS, Nepomuceno R, Cirelli T, Dos Santos RA, Takahashi CS, Rocha CS, Orrico SRP, Maurer-Morelli CV, Scarel-Caminaga RM. Expression Profile of Genes Potentially Associated with Adequate Glycemic Control in Patients with Type 2 Diabetes Mellitus. J Diabetes Res 2017;2017:2180819. [PMID: 28812028 DOI: 10.1155/2017/2180819] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
142 Maciejewski BS, LaPerle JL, Chen D, Ghosh A, Zavadoski WJ, McDonald TS, Manion TB, Mather D, Patterson TA, Hanna M, Watkins S, Gibbs EM, Calle RA, Steppan CM. Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans. Am J Physiol Gastrointest Liver Physiol 2013;304:G958-69. [PMID: 23558010 DOI: 10.1152/ajpgi.00384.2012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
143 Lula EC, Ribeiro CC, Hugo FN, Alves CM, Silva AA. Added sugars and periodontal disease in young adults: an analysis of NHANES III data. The American Journal of Clinical Nutrition 2014;100:1182-7. [DOI: 10.3945/ajcn.114.089656] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
144 Perry BD, Rahnert JA, Xie Y, Zheng B, Woodworth-Hobbs ME, Price SR. Palmitate-induced ER stress and inhibition of protein synthesis in cultured myotubes does not require Toll-like receptor 4. PLoS One 2018;13:e0191313. [PMID: 29329354 DOI: 10.1371/journal.pone.0191313] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
145 Asbaghi O, Fouladvand F, Moradi S, Ashtary-Larky D, Choghakhori R, Abbasnezhad A. Effect of green tea extract on lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Metab Syndr 2020;14:293-301. [PMID: 32289742 DOI: 10.1016/j.dsx.2020.03.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
146 Hempel R, Onopa R, Convit A. Type 2 diabetes affects hippocampus volume differentially in men and women. Diabetes Metab Res Rev 2012;28:76-83. [PMID: 21695767 DOI: 10.1002/dmrr.1230] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
147 Yang Y, Song W. Molecular links between Alzheimer’s disease and diabetes mellitus. Neuroscience. 2013;250:140-150. [PMID: 23867771 DOI: 10.1016/j.neuroscience.2013.07.009] [Cited by in Crossref: 117] [Cited by in F6Publishing: 113] [Article Influence: 13.0] [Reference Citation Analysis]
148 Bhakkiyalakshmi E, Sireesh D, Sakthivadivel M, Sivasubramanian S, Gunasekaran P, Ramkumar KM. Anti-hyperlipidemic and anti-peroxidative role of pterostilbene via Nrf2 signaling in experimental diabetes. European Journal of Pharmacology 2016;777:9-16. [DOI: 10.1016/j.ejphar.2016.02.054] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
149 Sips FL, Nyman E, Adiels M, Hilbers PA, Strålfors P, van Riel NA, Cedersund G. Model-Based Quantification of the Systemic Interplay between Glucose and Fatty Acids in the Postprandial State. PLoS One 2015;10:e0135665. [PMID: 26356502 DOI: 10.1371/journal.pone.0135665] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
150 Dixit AK, Dey R, Suresh A, Chaudhuri S, Panda AK, Mitra A, Hazra J. The prevalence of dyslipidemia in patients with diabetes mellitus of ayurveda Hospital. J Diabetes Metab Disord 2014;13:58. [PMID: 24918095 DOI: 10.1186/2251-6581-13-58] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
151 Han J, Kim SH, Suh YJ, Lim HA, Shin H, Cho SG, Kim CW, Lee SY, Lee DH, Hong S, Kim YS, Nam MS. Serum Chemerin Levels Are Associated with Abdominal Visceral Fat in Type 2 Diabetes. J Korean Med Sci 2016;31:924-31. [PMID: 27247502 DOI: 10.3346/jkms.2016.31.6.924] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
152 Singla R, Ambekar S, Nand K, Singh MB, Gupta N, Jyotsna VP. Profile of type 2 diabetes mellitus without overt complications of diabetes mellitus at a tertiary care center. Indian J Endocrinol Metab 2012;16:S468-70. [PMID: 23565469 DOI: 10.4103/2230-8210.104134] [Reference Citation Analysis]
153 Jariyapongskul A, Areebambud C, Suksamrarn S, Mekseepralard C. Alpha-mangostin attenuation of hyperglycemia-induced ocular hypoperfusion and blood retinal barrier leakage in the early stage of type 2 diabetes rats. Biomed Res Int 2015;2015:785826. [PMID: 25950001 DOI: 10.1155/2015/785826] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
154 Kotani K, Kimura S, Ebara T, Caccavello R, Gugliucci A. Serum aspirin esterase is strongly associated with glucose and lipids in healthy subjects: different association patterns in subjects with type 2 diabetes mellitus. Diabetol Metab Syndr 2010;2:50. [PMID: 20659351 DOI: 10.1186/1758-5996-2-50] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
155 Sanz-Serra P, Pedro-Botet J, Flores-Le Roux JA, Benaiges D, Chillarón JJ. [Dapagliflozin: Beyond glycemic control in the treatment of type 2 diabetes mellitus]. Clin Investig Arterioscler 2015;27:205-11. [PMID: 25648671 DOI: 10.1016/j.arteri.2014.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
156 Rašković A, Ćućuz V, Torović L, Tomas A, Gojković-Bukarica L, Ćebović T, Milijašević B, Stilinović N, Cvejić Hogervorst J. Resveratrol supplementation improves metabolic control in rats with induced hyperlipidemia and type 2 diabetes. Saudi Pharm J 2019;27:1036-43. [PMID: 31997911 DOI: 10.1016/j.jsps.2019.08.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
157 Alharbi KK, Khan IA, Al-Daghri NM, Munshi A, Sharma V, Mohammed AK, Wani KA, Al-Sheikh YA, Al-Nbaheen MS, Ansari MG, Syed R. ABCA1 C69T gene polymorphism and risk of type 2 diabetes mellitus in a Saudi population. J Biosci 2013;38:893-7. [PMID: 24296892 DOI: 10.1007/s12038-013-9384-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
158 Ye X, Jiang R, Zhang Q, Wang R, Yang C, Ma J, Du H. Increased 8-hydroxy-2'-deoxyguanosine in leukocyte DNA from patients with type 2 diabetes and microangiopathy. J Int Med Res 2016;44:472-82. [PMID: 27009027 DOI: 10.1177/0300060515621530] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
159 Sharma N, Garg V, Paul A. Antihyperglycemic, antihyperlipidemic and antioxidative potential of Prosopis cineraria bark. Indian J Clin Biochem 2010;25:193-200. [PMID: 23105909 DOI: 10.1007/s12291-010-0035-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
160 Ghadge AA, Diwan AG, Harsulkar AM, Kuvalekar AA. Gender dependent effects of fasting blood glucose levels and disease duration on biochemical markers in type 2 diabetics: A pilot study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2017;11:S481-9. [DOI: 10.1016/j.dsx.2017.03.041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
161 Tong X, Lv P, Mathew AV, Liu D, Niu C, Wang Y, Ji L, Li J, Fu Z, Pan B. The compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus. Cardiovasc Diabetol. 2014;13:82. [PMID: 24751283 DOI: 10.1186/1475-2840-13-82] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
162 Chehade JM, Gladysz M, Mooradian AD. Dyslipidemia in Type 2 Diabetes: Prevalence, Pathophysiology, and Management. Drugs 2013;73:327-39. [DOI: 10.1007/s40265-013-0023-5] [Cited by in Crossref: 111] [Cited by in F6Publishing: 97] [Article Influence: 12.3] [Reference Citation Analysis]
163 Daryabor G, Atashzar MR, Kabelitz D, Meri S, Kalantar K. The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System. Front Immunol 2020;11:1582. [PMID: 32793223 DOI: 10.3389/fimmu.2020.01582] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
164 Hanafi MY, Saad MI, Abdelkhalek TM, Saleh MM, Kamel MA. In Utero Nutritional Manipulation Provokes Dysregulated Adipocytokines Production in F1 Offspring in Rats. Scientifica (Cairo) 2016;2016:3892890. [PMID: 27200209 DOI: 10.1155/2016/3892890] [Reference Citation Analysis]
165 Hashim KN, Chin KY, Ahmad F. The Mechanism of Honey in Reversing Metabolic Syndrome. Molecules 2021;26:808. [PMID: 33557218 DOI: 10.3390/molecules26040808] [Reference Citation Analysis]
166 Fernando ME, Crowther RG, Cunningham M, Lazzarini PA, Sangla KS, Golledge J. Lower limb biomechanical characteristics of patients with neuropathic diabetic foot ulcers: the diabetes foot ulcer study protocol. BMC Endocr Disord 2015;15:59. [PMID: 26499881 DOI: 10.1186/s12902-015-0057-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
167 Trepanowski JF, Varady KA. Veganism Is a Viable Alternative to Conventional Diet Therapy for Improving Blood Lipids and Glycemic Control. Critical Reviews in Food Science and Nutrition 2014;55:2004-13. [DOI: 10.1080/10408398.2012.736093] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
168 Muzaffar H, Faisal MN, Anwar H, Hussain A, Khan JA, Muhammad F, Aslam B, Mahmood A, Abdelsadik A, Aslam J, Manzoor MF, Ahmad N, Karrar E. Fish protein intake is a novel dietary approach for managing diabetes-associated complications in diabetic Wistar rat model. Food Sci Nutr 2021;9:1017-24. [PMID: 33598184 DOI: 10.1002/fsn3.2069] [Reference Citation Analysis]
169 Laimoud M, Faris F, Elghawaby H. Intravascular evaluation of coronary atherosclerotic lesions among Egyptian diabetic patients with acute coronary syndromes. Egypt Heart J 2018;70:237-41. [PMID: 30591736 DOI: 10.1016/j.ehj.2018.10.003] [Reference Citation Analysis]
170 Safari S, Amini M, Aminorroaya A, Feizi A. Patterns of changes in serum lipid profiles in prediabetic subjects: results from a 16-year prospective cohort study among first-degree relatives of type 2 diabetic patients. Lipids Health Dis 2020;19:193. [PMID: 32829710 DOI: 10.1186/s12944-020-01371-y] [Reference Citation Analysis]
171 Krishnadath IS, Nahar-van Venrooij LM, Jaddoe VW, Toelsie JR. Ethnic differences in prediabetes and diabetes in the Suriname Health Study. BMJ Open Diabetes Res Care 2016;4:e000186. [PMID: 27403324 DOI: 10.1136/bmjdrc-2015-000186] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
172 Willecke F, Scerbo D, Nagareddy P, Obunike JC, Barrett TJ, Abdillahi ML, Trent CM, Huggins LA, Fisher EA, Drosatos K, Goldberg IJ. Lipolysis, and not hepatic lipogenesis, is the primary modulator of triglyceride levels in streptozotocin-induced diabetic mice. Arterioscler Thromb Vasc Biol 2015;35:102-10. [PMID: 25395613 DOI: 10.1161/ATVBAHA.114.304615] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
173 Chen J, Pu Y, Pei H, He L, Fu S, Chen L. Synthesis and biological evaluation of tert-butyl-5-methylpyrimidin-piperazine derivatives as anti-obesity agents. Arch Pharm (Weinheim) 2014;347:908-22. [PMID: 25220533 DOI: 10.1002/ardp.201400227] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
174 Shetty SS, Kumari NS. Fatty acid desaturase 2 (FADS 2) rs174575 (C/G) polymorphism, circulating lipid levels and susceptibility to type-2 diabetes mellitus. Sci Rep 2021;11:13151. [PMID: 34162950 DOI: 10.1038/s41598-021-92572-7] [Reference Citation Analysis]
175 Wang S, Yong H, He XD. Multi-omics: Opportunities for research on mechanism of type 2 diabetes mellitus. World J Diabetes 2021; 12(7): 1070-1080 [PMID: 34326955 DOI: 10.4239/wjd.v12.i7.1070] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Cariou B, Leiter LA, Müller-Wieland D, Bigot G, Colhoun HM, Del Prato S, Henry RR, Tinahones FJ, Letierce A, Aurand L, Maroni J, Ray KK, Bujas-Bobanovic M. Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trial. Diabetes Metab 2017;43:453-9. [PMID: 28347654 DOI: 10.1016/j.diabet.2017.01.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
177 Vargas-Alarcón G, González-Salazar MDC, Vázquez-Vázquez C, Hernández-Díaz Couder A, Sánchez-Muñoz F, Reyes-Barrera J, Criales-Vera SA, Sánchez-Guerra M, Osorio-Yáñez C, Posadas-Sánchez R. The rs12617336 and rs17574 Dipeptidyl Peptidase-4 Polymorphisms Are Associated With Hypoalphalipoproteinemia and Dipeptidyl Peptidase-4 Serum Levels: A Case-Control Study of the Genetics of Atherosclerotic Disease (GEA) Cohort. Front Genet 2021;12:592646. [PMID: 34178021 DOI: 10.3389/fgene.2021.592646] [Reference Citation Analysis]
178 Yang T, Zhao B, Pei D. Relationship between the ApoB/ApoA-I ratio trajectory and risk of type 2 diabetes in China: a retrospective cohort study. Endocrine 2022. [PMID: 35032012 DOI: 10.1007/s12020-021-02961-1] [Reference Citation Analysis]
179 Schiller K, Jacobs S, Jansen E, Weikert C, di Giuseppe R, Boeing H, Schulze M, Kröger J. Associated factors of estimated desaturase activity in the EPIC-Potsdam study. Nutrition, Metabolism and Cardiovascular Diseases 2014;24:503-10. [DOI: 10.1016/j.numecd.2013.10.029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
180 Yang XL, Chan JC. Diabetes, insulin and cancer risk. World J Diabetes 2012; 3(4): 60-64 [PMID: 22532884 DOI: 10.4239/wjd.v3.i4.60] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
181 Munir R, Usman H, Hasnain S, Smans K, Kalbacher H, Zaidi N. Atypical plasma lipid profile in cancer patients: cause or consequence? Biochimie 2014;102:9-18. [PMID: 24704108 DOI: 10.1016/j.biochi.2014.03.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
182 Dongway AC, Faggad AS, Zaki HY, Abdalla BE. C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese. Diabetes Metab Syndr Obes 2015;8:427-35. [PMID: 26379442 DOI: 10.2147/DMSO.S85451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
183 Solanki JD, Makwana AH, Mehta HB, Gokhale PA, Shah CJ. Is the peripheral arterial disease in low risk type 2 diabetic patients influenced by body mass index, lipidemic control, and statins? J Pharmacol Pharmacother 2016;7:87-92. [PMID: 27440953 DOI: 10.4103/0976-500X.184772] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
184 Merrill AK, Anderson T, Conrad K, Marvin E, James-Todd T, Cory-Slechta DA, Sobolewski M. Protracted Impairment of Maternal Metabolic Health in Mouse Dams Following Pregnancy Exposure to a Mixture of Low Dose Endocrine-Disrupting Chemicals, a Pilot Study. Toxics 2021;9:346. [PMID: 34941779 DOI: 10.3390/toxics9120346] [Reference Citation Analysis]
185 Barter PJ. High density lipoprotein: a therapeutic target in type 2 diabetes. Endocrinol Metab (Seoul) 2013;28:169-77. [PMID: 24396675 DOI: 10.3803/EnM.2013.28.3.169] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
186 Slimani A, Hrira MY, Najah M, Jomaa W, Maatouk F, Hamda KB, Abifadel M, Rabès J, Boileau C, Rouis M, Slimane MN, Varret M. PCSK9 polymorphism in a Tunisian cohort: Identification of a new allele, L8, and association of allele L10 with reduced coronary heart disease risk. Molecular and Cellular Probes 2015;29:1-6. [DOI: 10.1016/j.mcp.2014.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
187 Yen CH, Chu YJ, Lee BJ, Lin YC, Lin PT. Effect of liquid ubiquinol supplementation on glucose, lipids and antioxidant capacity in type 2 diabetes patients: a double-blind, randomised, placebo-controlled trial. Br J Nutr 2018;120:57-63. [PMID: 29936921 DOI: 10.1017/S0007114518001241] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
188 Wu G, Li GB, Dai B, Zhang DQ. Novel KIF6 polymorphism increases susceptibility to type 2 diabetes mellitus and coronary heart disease in Han Chinese men. J Diabetes Res 2014;2014:871439. [PMID: 25629058 DOI: 10.1155/2014/871439] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
189 Imam MU, Azmi NH, Bhanger MI, Ismail N, Ismail M. Antidiabetic properties of germinated brown rice: a systematic review. Evid Based Complement Alternat Med 2012;2012:816501. [PMID: 23304216 DOI: 10.1155/2012/816501] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
190 Abdel Hay R, Samir N, Safwat M, Rashed L, Soliman M. Tissue lipocalin-2 in psoriasis: is it a marker of metabolic disturbance or a possible marker of therapeutic efficacy after narrow band ultraviolet B? J Dermatolog Treat 2020;31:519-23. [PMID: 30995143 DOI: 10.1080/09546634.2019.1605141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
191 Yoshikawa M, Asaba K, Nakayama T. Estimating causal effects of atherogenic lipid-related traits on COVID-19 susceptibility and severity using a two-sample Mendelian randomization approach. BMC Med Genomics 2021;14:269. [PMID: 34774031 DOI: 10.1186/s12920-021-01127-2] [Reference Citation Analysis]
192 Bahrami A, Barreto GE, Lombardi G, Pirro M, Sahebkar A. Emerging roles for high‐density lipoproteins in neurodegenerative disorders. BioFactors 2019;45:725-39. [DOI: 10.1002/biof.1541] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
193 Chen C, Huang Q, Li C, Fu X. Hypoglycemic effects of a Fructus Mori polysaccharide in vitro and in vivo. Food Funct 2017;8:2523-35. [DOI: 10.1039/c7fo00417f] [Cited by in Crossref: 34] [Cited by in F6Publishing: 7] [Article Influence: 6.8] [Reference Citation Analysis]
194 Mills S, Stanton C, Lane JA, Smith GJ, Ross RP. Precision Nutrition and the Microbiome, Part I: Current State of the Science. Nutrients. 2019;11:923. [PMID: 31022973 DOI: 10.3390/nu11040923] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 25.7] [Reference Citation Analysis]
195 Cheon SY, Cho K. Lipid metabolism, inflammation, and foam cell formation in health and metabolic disorders: targeting mTORC1. J Mol Med (Berl) 2021. [PMID: 34312684 DOI: 10.1007/s00109-021-02117-8] [Reference Citation Analysis]
196 Lumu W, Kampiire L, Akabwai GP, Ssekitoleko R, Kiggundu DS, Kibirige D. Dyslipidaemia in a Black African diabetic population: burden, pattern and predictors. BMC Res Notes 2017;10:587. [PMID: 29121994 DOI: 10.1186/s13104-017-2916-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
197 Alasmary FAS, Alnahdi FS, Ben Bacha A, El-Araby AM, Moubayed N, Alafeefy AM, El-Araby ME. New quinoxalinone inhibitors targeting secreted phospholipase A2 and α-glucosidase. J Enzyme Inhib Med Chem 2017;32:1143-51. [PMID: 28856929 DOI: 10.1080/14756366.2017.1363743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
198 Apro J, Parini P, Broijersén A, Angelin B, Rudling M. Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients. J Lipid Res 2015;56:1633-9. [PMID: 26092865 DOI: 10.1194/jlr.P058842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
199 Ramachandran S, Rajasekaran A, Adhirajan N. In Vivo and In Vitro Antidiabetic Activity of Terminalia paniculata Bark: An Evaluation of Possible Phytoconstituents and Mechanisms for Blood Glucose Control in Diabetes. ISRN Pharmacol 2013;2013:484675. [PMID: 23936668 DOI: 10.1155/2013/484675] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
200 Almourani R, Chinnakotla B, Patel R, Kurukulasuriya LR, Sowers J. Diabetes and Cardiovascular Disease: an Update. Curr Diab Rep 2019;19. [DOI: 10.1007/s11892-019-1239-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
201 Huang HY, Korivi M, Tsai CH, Yang JH, Tsai YC. Supplementation of Lactobacillus plantarum K68 and Fruit-Vegetable Ferment along with High Fat-Fructose Diet Attenuates Metabolic Syndrome in Rats with Insulin Resistance. Evid Based Complement Alternat Med. 2013;2013:943020. [PMID: 23690866 DOI: 10.1155/2013/943020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
202 Rahman ML, Feng YA, Fiehn O, Albert PS, Tsai MY, Zhu Y, Wang X, Tekola-Ayele F, Liang L, Zhang C. Plasma lipidomics profile in pregnancy and gestational diabetes risk: a prospective study in a multiracial/ethnic cohort. BMJ Open Diabetes Res Care 2021;9:e001551. [PMID: 33674279 DOI: 10.1136/bmjdrc-2020-001551] [Reference Citation Analysis]
203 Sips FL, Tiemann CA, Oosterveer MH, Groen AK, Hilbers PA, van Riel NA. A computational model for the analysis of lipoprotein distributions in the mouse: translating FPLC profiles to lipoprotein metabolism. PLoS Comput Biol 2014;10:e1003579. [PMID: 24784354 DOI: 10.1371/journal.pcbi.1003579] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
204 Washirasaksiri C, Srivanichakorn W, Godsland IF, Kositamongkol C, Chariyalertsak S, Kessomboon P, Assanangkornchai S, Taneepanichskul S, Neelapaichit N, Phisalprapa P, Johnston DG, Oliver NS, Aekplakorn W. Increasing glycaemia is associated with a significant decline in HDL cholesterol in women with prediabetes in two national populations. Sci Rep 2021;11:12194. [PMID: 34108497 DOI: 10.1038/s41598-021-91075-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
205 Barrett TJ, Murphy AJ, Goldberg IJ, Fisher EA. Diabetes-mediated myelopoiesis and the relationship to cardiovascular risk. Ann N Y Acad Sci 2017;1402:31-42. [PMID: 28926114 DOI: 10.1111/nyas.13462] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
206 Luo Y, Li J, Zhang J, Xu Y. Low HDL cholesterol is correlated to the acute ischemic stroke with diabetes mellitus. Lipids Health Dis 2014;13:171. [PMID: 25395241 DOI: 10.1186/1476-511X-13-171] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
207 Maleki V, Mahdavi R, Hajizadeh-Sharafabad F, Alizadeh M. The effects of taurine supplementation on oxidative stress indices and inflammation biomarkers in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Diabetol Metab Syndr 2020;12:9. [PMID: 32015761 DOI: 10.1186/s13098-020-0518-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
208 Stančáková A, Paananen J, Soininen P, Kangas AJ, Bonnycastle LL, Morken MA, Collins FS, Jackson AU, Boehnke ML, Kuusisto J, Ala-Korpela M, Laakso M. Effects of 34 risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses and their composition in 6,580 nondiabetic Finnish men. Diabetes 2011;60:1608-16. [PMID: 21421807 DOI: 10.2337/db10-1655] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 5.0] [Reference Citation Analysis]
209 Sprandel MC, Hueb WA, Segre A, Ramires JA, Kalil-Filho R, Maranhão RC. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 2015;14:107. [PMID: 26268997 DOI: 10.1186/s12933-015-0270-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
210 Pavlović N, Stankov K, Mikov M. Probiotics—Interactions with Bile Acids and Impact on Cholesterol Metabolism. Appl Biochem Biotechnol 2012;168:1880-95. [DOI: 10.1007/s12010-012-9904-4] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
211 Taub R, Chiang E, Chabot-blanchet M, Kelly MJ, Reeves RA, Guertin M, Tardif J. Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist. Atherosclerosis 2013;230:373-80. [DOI: 10.1016/j.atherosclerosis.2013.07.056] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 5.8] [Reference Citation Analysis]
212 Xiong W, Gu L, Wang C, Sun H, Liu X. Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice. Journal of Ethnopharmacology 2013;150:935-45. [DOI: 10.1016/j.jep.2013.09.027] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
213 Zhang Y, Jin, An X, Duan L, Duan Y, Lian F. Lychee Seed as a Potential Hypoglycemic Agent, and Exploration of its Underlying Mechanisms. Front Pharmacol 2021;12:737803. [PMID: 34690773 DOI: 10.3389/fphar.2021.737803] [Reference Citation Analysis]
214 Fu Z, Abou-Samra AB, Zhang R. A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase. Sci Rep 2015;5:18502. [PMID: 26687026 DOI: 10.1038/srep18502] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 6.6] [Reference Citation Analysis]
215 Roh E, Ko SH, Kwon HS, Kim NH, Kim JH, Kim CS, Song KH, Won JC, Kim DJ, Choi SH, Lim S, Cha BY; Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010. Diabetes Metab J 2013;37:433-49. [PMID: 24404515 DOI: 10.4093/dmj.2013.37.6.433] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 7.6] [Reference Citation Analysis]
216 Yang X, So WY, Ma RC, Kong AP, Lee HM, Yu LW, Chow CC, Ozaki R, Ko GT, Chan JC. Low HDL cholesterol, metformin use, and cancer risk in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes Care. 2011;34:375-380. [PMID: 20980414 DOI: 10.2337/dc10-1509] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
217 Lim E, Lim JY, Kim E, Kim YS, Shin JH, Seok PR, Jung S, Yoo SH, Kim Y. Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice. Nutrients 2016;8:E791. [PMID: 27929393 DOI: 10.3390/nu8120791] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
218 Mohan T, Velusamy P, Chakrapani LN, Srinivasan AK, Singh A, Johnson T, Periandavan K. Impact of EGCG Supplementation on the Progression of Diabetic Nephropathy in Rats: An Insight into Fibrosis and Apoptosis. J Agric Food Chem 2017;65:8028-36. [DOI: 10.1021/acs.jafc.7b03301] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
219 Schindler MSZ, Calisto JFF, Marins K, Regginato A, Mezzomo H, Zanatta AP, Radunz AL, Mariot MP, Dal Magro J, Zanatta L. Characterization of the chemical profile and the effects of ethanolic extracts of Maytenus ilicifolia Mart. ex Reissek on glucose metabolism in normal hyperglycemic rats. J Ethnopharmacol 2021;276:114173. [PMID: 33932519 DOI: 10.1016/j.jep.2021.114173] [Reference Citation Analysis]
220 Zhang R. The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking. Open Biol 2016;6:150272. [PMID: 27053679 DOI: 10.1098/rsob.150272] [Cited by in Crossref: 117] [Cited by in F6Publishing: 110] [Article Influence: 19.5] [Reference Citation Analysis]
221 Tan XW, Takenaka F, Takekawa H, Mastuura E. Rapid and specific detection of oxidized LDL/β2GPI complexes via facile lateral flow immunoassay. Heliyon 2020;6:e04114. [PMID: 32551380 DOI: 10.1016/j.heliyon.2020.e04114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
222 Ling Y, Hao ZY, Liang D, Zhang CL, Liu YF, Wang Y. The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design. Drug Des Devel Ther 2021;15:4289-338. [PMID: 34675489 DOI: 10.2147/DDDT.S329547] [Reference Citation Analysis]
223 Zhao D, Yang LY, Wang XH, Yuan SS, Yu CG, Wang ZW, Lang JN, Feng YM. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients. Cardiovasc Diabetol 2016;15:132. [PMID: 27620179 DOI: 10.1186/s12933-016-0450-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
224 Sun QX, Zhou HM, Du QW. Association of Rs2071410 on Furin with Transient Ischemic Attack Susceptibility and Prognosis in a Chinese Population. Med Sci Monit 2016;22:3828-34. [PMID: 27760099 DOI: 10.12659/msm.897122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
225 Toth PP. Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease. Vasc Health Risk Manag 2015;11:9-23. [PMID: 25565858 DOI: 10.2147/VHRM.S75215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
226 Morsi HK, Ismail MM, Gaber HA, Elbasmy AA. Macrophage Migration Inhibitory Factor and Malondialdehyde as Potential Predictors of Vascular Risk Complications in Type 2 Diabetes Mellitus: Cross-Sectional Case Control Study in Saudi Arabia. Mediators Inflamm 2016;2016:5797930. [PMID: 27298517 DOI: 10.1155/2016/5797930] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
227 McEwen B, Morel-Kopp MC, Tofler G, Ward C. Effect of omega-3 fish oil on cardiovascular risk in diabetes. Diabetes Educ. 2010;36:565-584. [PMID: 20534874 DOI: 10.1177/0145721710372675] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
228 Liu Z, Qu CY, Li JX, Wang YF, Li W, Wang CZ, Wang DS, Song J, Sun GZ, Yuan CS. Hypoglycemic and Hypolipidemic Effects of Malonyl Ginsenosides from American Ginseng (Panax quinquefolius L.) on Type 2 Diabetic Mice. ACS Omega 2021;6:33652-64. [PMID: 34926913 DOI: 10.1021/acsomega.1c04656] [Reference Citation Analysis]
229 El-bassossy HM, Ghaleb H, Elberry AA, Balamash KS, Ghareib SA, Azhar A, Banjar Z. Geraniol alleviates diabetic cardiac complications: Effect on cardiac ischemia and oxidative stress. Biomedicine & Pharmacotherapy 2017;88:1025-30. [DOI: 10.1016/j.biopha.2017.01.131] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
230 Bhat S, Yatsynovich Y, Sharma UC. Coronary revascularization in patients with stable coronary disease and diabetes mellitus. Diab Vasc Dis Res 2021;18:14791641211002469. [PMID: 33926268 DOI: 10.1177/14791641211002469] [Reference Citation Analysis]
231 Ding QY, Tian JX, Li M, Lian FM, Zhao LH, Wei XX, Han L, Zheng YJ, Gao ZZ, Yang HY, Fang XY, Tong XL. Interactions Between Therapeutics for Metabolic Disease, Cardiovascular Risk Factors, and Gut Microbiota. Front Cell Infect Microbiol 2020;10:530160. [PMID: 33194785 DOI: 10.3389/fcimb.2020.530160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
232 Mazón-Ramos P, Cordero A, González-Juanatey JR, Bertomeu Martínez V, Delgado E, Vitale G, Fernández-Anaya S. Control of cardiovascular risk factors in revascularized patients with diabetes: a subanalysis of the ICP-Bypass study. Rev Esp Cardiol (Engl Ed) 2015;68:115-20. [PMID: 25224523 DOI: 10.1016/j.rec.2014.03.021] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
233 Handelsman Y, Lepor NE. PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review. J Am Heart Assoc 2018;7:e008953. [PMID: 29934421 DOI: 10.1161/JAHA.118.008953] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
234 Yang ZH, Miyahara H, Iwasaki Y, Takeo J, Katayama M. Dietary supplementation with long-chain monounsaturated fatty acids attenuates obesity-related metabolic dysfunction and increases expression of PPAR gamma in adipose tissue in type 2 diabetic KK-Ay mice. Nutr Metab (Lond) 2013;10:16. [PMID: 23360495 DOI: 10.1186/1743-7075-10-16] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
235 Duan H, Ning F, Zhang D, Wang S, Zhang D, Tan Q, Tian X, Pang Z. The Qingdao Twin Registry: a status update. Twin Res Hum Genet 2013;16:79-85. [PMID: 23182450 DOI: 10.1017/thg.2012.113] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
236 Aslanabadi N, Habibi Asl B, Bakhshalizadeh B, Ghaderi F, Nemati M. Hypolipidemic activity of a natural mineral water rich in calcium, magnesium, and bicarbonate in hyperlipidemic adults. Adv Pharm Bull. 2014;4:303-307. [PMID: 24754016 DOI: 10.5681/apb.2014.044] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
237 Movahedian M, Golzan SA, Ashtary-Larky D, Clark CCT, Asbaghi O, Hekmatdoost A. The effects of artificial- and stevia-based sweeteners on lipid profile in adults: a GRADE-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials. Crit Rev Food Sci Nutr 2021;:1-17. [PMID: 34882023 DOI: 10.1080/10408398.2021.2012641] [Reference Citation Analysis]
238 Pelgrim CE, Franx BAA, Snabel J, Kleemann R, Arnoldussen IAC, Kiliaan AJ. Butyrate Reduces HFD-Induced Adipocyte Hypertrophy and Metabolic Risk Factors in Obese LDLr-/-.Leiden Mice. Nutrients 2017;9:E714. [PMID: 28686216 DOI: 10.3390/nu9070714] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
239 Mullugeta Y, Chawla R, Kebede T, Worku Y. Dyslipidemia associated with poor glycemic control in type 2 diabetes mellitus and the protective effect of metformin supplementation. Indian J Clin Biochem 2012;27:363-9. [PMID: 24082461 DOI: 10.1007/s12291-012-0225-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
240 Mashayekhi-Sardoo H, Atkin SL, Montecucco F, Sahebkar A. Potential Alteration of Statin-Related Pharmacological Features in Diabetes Mellitus. Biomed Res Int 2021;2021:6698743. [PMID: 33834073 DOI: 10.1155/2021/6698743] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
241 Mariño L, Casasnovas R, Ramis R, Vilanova B, Ortega-castro J, Frau J, Adrover M. Does glycation really distort the peptide α-helicity? International Journal of Biological Macromolecules 2019;129:254-66. [DOI: 10.1016/j.ijbiomac.2019.01.213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
242 Aroner SA, Furtado JD, Sacks FM, Tsai MY, Mukamal KJ, McClelland RL, Jensen MK. Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis. Diabetologia 2019;62:981-92. [PMID: 30949716 DOI: 10.1007/s00125-019-4847-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
243 Steinberg HO. Sodium-glucose cotransporter 2 inhibitors and cardiovascular outcomes. Postgrad Med 2016;128:398-408. [PMID: 26999348 DOI: 10.1080/00325481.2016.1168687] [Reference Citation Analysis]
244 Bartelt A, John C, Schaltenberg N, Berbée JFP, Worthmann A, Cherradi ML, Schlein C, Piepenburg J, Boon MR, Rinninger F, Heine M, Toedter K, Niemeier A, Nilsson SK, Fischer M, Wijers SL, van Marken Lichtenbelt W, Scheja L, Rensen PCN, Heeren J. Thermogenic adipocytes promote HDL turnover and reverse cholesterol transport. Nat Commun 2017;8:15010. [PMID: 28422089 DOI: 10.1038/ncomms15010] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 13.2] [Reference Citation Analysis]
245 Tan XW, Kobayashi K, Shen L, Inagaki J, Ide M, Hwang SS, Matsuura E. Antioxidative attributes of rice bran extracts in ameliorative effects of atherosclerosis-associated risk factors. Heliyon 2020;6:e05743. [PMID: 33376820 DOI: 10.1016/j.heliyon.2020.e05743] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
246 Cheong MC, Lee HJ, Na K, Joo HJ, Avery L, You YJ, Paik YK. NSBP-1 mediates the effects of cholesterol on insulin/IGF-1 signaling in Caenorhabditis elegans. Cell Mol Life Sci 2013;70:1623-36. [PMID: 23255046 DOI: 10.1007/s00018-012-1221-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
247 Yang E, Yoo H, Jang IJ, Yu KS, Lee S. Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study. Drug Des Devel Ther 2021;15:651-8. [PMID: 33628012 DOI: 10.2147/DDDT.S288986] [Reference Citation Analysis]
248 Navghare V, Dhawale S. Suppression of Type-II Diabetes with Dyslipidemia and Nephropathy by Peels of Musa cavendish Fruit. Indian J Clin Biochem 2016;31:380-9. [PMID: 27605735 DOI: 10.1007/s12291-016-0548-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
249 Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomark Insights. 2016;11:95-104. [PMID: 27398023 DOI: 10.4137/bmi.s38440] [Cited by in Crossref: 203] [Cited by in F6Publishing: 107] [Article Influence: 33.8] [Reference Citation Analysis]
250 Ojo OA, Ojo AB, Ajiboye BO, Imiere OD, Oyinloye BE. Antihyperlipidemic Activities and Hematological Properties of Ethanol Extract of Blighia Sapida Koenig Bark in Alloxan-Induced Diabetic Rats. Serbian Journal of Experimental and Clinical Research 2020;21:11-7. [DOI: 10.2478/sjecr-2018-0042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
251 Watson SE, Li Z, Tu W, Jalou H, Brubaker JL, Gupta S, Huber JN, Carroll A, Hannon TS. Obstructive sleep apnoea in obese adolescents and cardiometabolic risk markers. Pediatr Obes 2014;9:471-7. [PMID: 24106092 DOI: 10.1111/j.2047-6310.2013.00198.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
252 Park S, Lee W, Chung HS, Hong KS. Diagnostic Utility of Serum Glycated Albumin for Diabetes Mellitus and Its Correlation With Hyperlipidemia. Ann Lab Med 2016;36:306-12. [PMID: 27139602 DOI: 10.3343/alm.2016.36.4.306] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
253 Mooradian AD. Evidence-Based Management of Diabetes in Older Adults. Drugs Aging 2018;35:1065-78. [PMID: 30306360 DOI: 10.1007/s40266-018-0598-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
254 Shimomura T, Wakabayashi I. Inverse associations between light-to-moderate alcohol intake and lipid-related indices in patients with diabetes. Cardiovasc Diabetol 2013;12:104. [PMID: 23866006 DOI: 10.1186/1475-2840-12-104] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
255 Hashemi R, Mehdizadeh Khalifani A, Rahimlou M, Manafi M. Comparison of the effect of Dietary Approaches to Stop Hypertension diet and American Diabetes Association nutrition guidelines on lipid profiles in patients with type 2 diabetes: A comparative clinical trial. Nutr Diet 2020;77:204-11. [PMID: 31162810 DOI: 10.1111/1747-0080.12543] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
256 Pelham JH, Hanks L, Aslibekyan S, Dowla S, Ashraf AP. Higher hemoglobin A1C and atherogenic lipoprotein profiles in children and adolescents with type 2 diabetes mellitus. J Clin Transl Endocrinol 2019;15:30-4. [PMID: 30547005 DOI: 10.1016/j.jcte.2018.11.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
257 Kumar B, Kowluru A, Kowluru RA. Lipotoxicity augments glucotoxicity-induced mitochondrial damage in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci 2015;56:2985-92. [PMID: 26024084 DOI: 10.1167/iovs.15-16466] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 6.4] [Reference Citation Analysis]
258 Jangjo-Borazjani S, Dastgheib M, Kiyamarsi E, Jamshidi R, Rahmati-Ahmadabad S, Helalizadeh M, Iraji R, Cornish SM, Mohammadi-Darestani S, Khojasteh Z, Azarbayjani MA. Effects of resistance training and nigella sativa on type 2 diabetes: implications for metabolic markers, low-grade inflammation and liver enzyme production. Arch Physiol Biochem 2021;:1-9. [PMID: 33612031 DOI: 10.1080/13813455.2021.1886117] [Reference Citation Analysis]
259 Jakuš V, Sándorová E, Kalninová J, Krahulec B. Monitoring of glycation, oxidative stress and inflammation in relation to the occurrence of vascular complications in patients with type 2 diabetes mellitus. Physiol Res 2014;63:297-309. [PMID: 24564602 DOI: 10.33549/physiolres.932672] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
260 Reith C, Armitage J. Management of residual risk after statin therapy. Atherosclerosis 2016;245:161-70. [DOI: 10.1016/j.atherosclerosis.2015.12.018] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
261 Mihardja L, Soetrisno U, Soegondo S. Prevalence and clinical profile of diabetes mellitus in productive aged urban Indonesians. J Diabetes Investig 2014;5:507-12. [PMID: 25411617 DOI: 10.1111/jdi.12177] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
262 Ambery P, Stylianou A, Atkinson G, Dott C, Baylor Curtis L, Haque N, LaCroix K, Min KW; Glimepiride/Atorvastatin Investigational Team. Open-label randomized non-inferiority trial of a fixed-dose combination of glimepiride and atorvastatin for the treatment of people whose Type 2 diabetes is uncontrolled on metformin. Diabet Med 2016;33:1084-93. [PMID: 26484794 DOI: 10.1111/dme.13003] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
263 Saad MI, Kamel MA, Hanafi MY. Modulation of Adipocytokines Production and Serum NEFA Level by Metformin, Glimepiride, and Sitagliptin in HFD/STZ Diabetic Rats. Biochem Res Int 2015;2015:138134. [PMID: 25838947 DOI: 10.1155/2015/138134] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
264 Nagarathna R, Kaur N, Anand A, Sharma K, Dada R, Sridhar P, Sharma P, Kumar Singh A, Patil S, Nagendra HR. Distribution of glycated haemoglobin and its determinants in Indian young adults. Diabetes Res Clin Pract 2020;159:107982. [PMID: 31846666 DOI: 10.1016/j.diabres.2019.107982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
265 Maciejewski BS, Manion TB, Steppan CM. Pharmacological inhibition of diacylglycerol acyltransferase-1 and insights into postprandial gut peptide secretion. World J Gastrointest Pathophysiol 2017; 8(4): 161-175 [PMID: 29184702 DOI: 10.4291/wjgp.v8.i4.161] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
266 Wolide AD, Zawdie B, Alemayehu T, Tadesse S. Association between thyroid hormone parameters and dyslipidemia among type 2 diabetes mellitus patients: Comparative cross-sectional study. Diabetes Metab Syndr 2017;11 Suppl 1:S257-62. [PMID: 28057507 DOI: 10.1016/j.dsx.2016.12.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
267 Schmidt C, Bergström G. Carotid Artery Intima-Media Thickness Predicts Major Cardiovascular Events During 7-Year Follow-Up in 64-Year-Old Women Irrespective of Other Glucometabolic Factors. Angiology 2017;68:553-8. [PMID: 27729556 DOI: 10.1177/0003319716672526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
268 Almetwazi M, Alwhaibi M, Balkhi B, Almohaini H, Alturki H, Alhawassi T, Ata S, AlQahtani N, Mahmoud M, Alshammari T. Factors associated with glycemic control in type 2 diabetic patients in Saudi Arabia. Saudi Pharm J 2019;27:384-8. [PMID: 30976182 DOI: 10.1016/j.jsps.2018.12.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
269 Kim MJ, Lim Y. Protective effect of short-term genistein supplementation on the early stage in diabetes-induced renal damage. Mediators Inflamm 2013;2013:510212. [PMID: 23737649 DOI: 10.1155/2013/510212] [Cited by in Crossref: 25] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
270 Esch N, Jo S, Moore M, Alejandro EU. Nutrient Sensor mTOR and OGT: Orchestrators of Organelle Homeostasis in Pancreatic β-Cells. J Diabetes Res 2020;2020:8872639. [PMID: 33457426 DOI: 10.1155/2020/8872639] [Reference Citation Analysis]
271 Lin Q, Fu Y, Zang X, Liu Q, Liu L. The Role of Fasting LDL-C Levels in Their Non-fasting Reduction in Patients With Coronary Heart Disease. Front Cardiovasc Med 2021;8:686234. [PMID: 34222380 DOI: 10.3389/fcvm.2021.686234] [Reference Citation Analysis]
272 Negrini TC, Carlos IZ, Duque C, Caiaffa KS, Arthur RA. Interplay Among the Oral Microbiome, Oral Cavity Conditions, the Host Immune Response, Diabetes Mellitus, and Its Associated-Risk Factors-An Overview. Front Oral Health 2021;2:697428. [PMID: 35048037 DOI: 10.3389/froh.2021.697428] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
273 Chaudhary R, Likidlilid A, Peerapatdit T, Tresukosol D, Srisuma S, Ratanamaneechat S, Sriratanasathavorn C. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease. Cardiovasc Diabetol. 2012;11:36. [PMID: 22520940 DOI: 10.1186/1475-2840-11-36] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 7.0] [Reference Citation Analysis]
274 Tawfik SH, Mahmoud BF, Saad MI, Shehata M, Kamel MA, Helmy MH. Similar and additive effects of ovariectomy and diabetes on insulin resistance and lipid metabolism. Biochem Res Int 2015;2015:567945. [PMID: 25834745 DOI: 10.1155/2015/567945] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
275 Xu X, Gopalacharyulu P, Seppänen-Laakso T, Ruskeepää AL, Aye CC, Carson BP, Mora S, Orešič M, Teleman AA. Insulin signaling regulates fatty acid catabolism at the level of CoA activation. PLoS Genet 2012;8:e1002478. [PMID: 22275878 DOI: 10.1371/journal.pgen.1002478] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 6.4] [Reference Citation Analysis]
276 Sunjaya AP, Sunjaya AF. Glycated hemoglobin targets and glycemic control: Link with lipid, uric acid and kidney profile. Diabetes Metab Syndr 2018;12:743-8. [PMID: 29709468 DOI: 10.1016/j.dsx.2018.04.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
277 Perak AM, Ning H, Kit BK, de Ferranti SD, Van Horn LV, Wilkins JT, Lloyd-Jones DM. Trends in Levels of Lipids and Apolipoprotein B in US Youths Aged 6 to 19 Years, 1999-2016. JAMA 2019;321:1895-905. [PMID: 31112258 DOI: 10.1001/jama.2019.4984] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
278 Sadeghian S, Shams M, Alipour Z, Saadat S, Hamidian R, Shahrzad M. Application of short message service to control blood cholesterol: a field trial. BMC Med Inform Decis Mak 2017;17:32. [PMID: 28351408 DOI: 10.1186/s12911-017-0427-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
279 Samino S, Vinaixa M, Díaz M, Beltran A, Rodríguez MA, Mallol R, Heras M, Cabre A, Garcia L, Canela N, de Zegher F, Correig X, Ibáñez L, Yanes O. Metabolomics reveals impaired maturation of HDL particles in adolescents with hyperinsulinaemic androgen excess. Sci Rep 2015;5:11496. [PMID: 26099471 DOI: 10.1038/srep11496] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
280 Chi XX, Zhang T, Zhang DJ, Yu W, Wang QY, Zhen JL. Effects of isoflavones on lipid and apolipoprotein levels in patients with type 2 diabetes in Heilongjiang Province in China. J Clin Biochem Nutr 2016;59:134-8. [PMID: 27698541 DOI: 10.3164/jcbn.15-147] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
281 Ghadge AA, Harsulkar AM, Diwan AG, Kuvalekar AA. Gender dependent differences in lipid metabolism in individuals with type 2 diabetes mellitus. J Diabetes Metab Disord 2020;19:967-77. [PMID: 33520816 DOI: 10.1007/s40200-020-00589-y] [Reference Citation Analysis]
282 de Souza Bastos A, Graves DT, de Melo Loureiro AP, Júnior CR, Corbi SCT, Frizzera F, Scarel-Caminaga RM, Câmara NO, Andriankaja OM, Hiyane MI, Orrico SRP. Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients. J Diabetes Complications 2016;30:1593-9. [PMID: 27497685 DOI: 10.1016/j.jdiacomp.2016.07.011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
283 Tsimihodimos V, Mikhailidis DP, Elisaf M. Summarizing the FIELD study: lessons from a ‘negative' trial. Expert Opinion on Pharmacotherapy 2013;14:2601-10. [DOI: 10.1517/14656566.2013.850075] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
284 Stähli BE, Gebhard C, Tardif JC. Lipid effects and cardiovascular disease risk associated with glucose-lowering medications. Curr Cardiol Rep 2015;17:608. [PMID: 26031672 DOI: 10.1007/s11886-015-0608-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
285 Reitz C, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol 2010;67:1491-7. [PMID: 21149810 DOI: 10.1001/archneurol.2010.297] [Cited by in Crossref: 111] [Cited by in F6Publishing: 119] [Article Influence: 10.1] [Reference Citation Analysis]
286 Kanwal F, Kramer JR, Li L, Dai J, Natarajan Y, Yu X, Asch SM, El‐serag HB. Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease. Hepatology 2020;71:808-19. [DOI: 10.1002/hep.31014] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 21.0] [Reference Citation Analysis]
287 Luo J, Zheng M, Jiang B, Li C, Guo S, Wang L, Li X, Yu R, Shi D. Antidiabetic activity in vitro and in vivo of BDB, a selective inhibitor of protein tyrosine phosphatase 1B, from Rhodomela confervoides. Br J Pharmacol 2020;177:4464-80. [PMID: 32663313 DOI: 10.1111/bph.15195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
288 Han Y, Zhang S, Chen S, Zhang J, Guo X, Yang X. Incidence and risk factors of type 2 diabetes mellitus in individuals with different fasting plasma glucose levels. Ther Adv Endocrinol Metab 2020;11:2042018820928844. [PMID: 32577198 DOI: 10.1177/2042018820928844] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
289 Razquin C, Toledo E, Clish CB, Ruiz-Canela M, Dennis C, Corella D, Papandreou C, Ros E, Estruch R, Guasch-Ferré M, Gómez-Gracia E, Fitó M, Yu E, Lapetra J, Wang D, Romaguera D, Liang L, Alonso-Gómez A, Deik A, Bullo M, Serra-Majem L, Salas-Salvadó J, Hu FB, Martínez-González MA. Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial. Diabetes Care 2018;41:2617-24. [PMID: 30327364 DOI: 10.2337/dc18-0840] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 14.3] [Reference Citation Analysis]
290 Wang JH, Bose S, Lim SK, Ansari A, Chin YW, Choi HS, Kim H. Houttuynia cordata Facilitates Metformin on Ameliorating Insulin Resistance Associated with Gut Microbiota Alteration in OLETF Rats. Genes (Basel) 2017;8:E239. [PMID: 28937612 DOI: 10.3390/genes8100239] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
291 Thomson M, Al-Qattan KK, Js D, Ali M. Anti-diabetic and anti-oxidant potential of aged garlic extract (AGE) in streptozotocin-induced diabetic rats. BMC Complement Altern Med 2016;16:17. [PMID: 26786785 DOI: 10.1186/s12906-016-0992-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
292 Al Mansour MA. The Prevalence and Risk Factors of Type 2 Diabetes Mellitus (DMT2) in a Semi-Urban Saudi Population. Int J Environ Res Public Health 2019;17:E7. [PMID: 31861311 DOI: 10.3390/ijerph17010007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
293 Rana K, Reid J, Rosenwasser JN, Lewis T, Sheikh-Ali M, Choksi RR, Goldfaden RF. A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data. Diabetes Metab Syndr Obes 2019;12:1897-911. [PMID: 31571964 DOI: 10.2147/DMSO.S167375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
294 Beccarelli LM, Scherr RE, Newman JW, Borkowska AG, Gray IJ, Linnell JD, Keen CL, Young HM. Associations Among Fatty Acids, Desaturase and Elongase, and Insulin Resistance in Children. J Am Coll Nutr 2018;37:44-50. [PMID: 29043930 DOI: 10.1080/07315724.2017.1347908] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
295 Kang P, Shin HY, Kim KY. Association between Dyslipidemia and Mercury Exposure in Adults. Int J Environ Res Public Health 2021;18:E775. [PMID: 33477628 DOI: 10.3390/ijerph18020775] [Reference Citation Analysis]
296 Tay J, Thompson CH, Luscombe-marsh ND, Wycherley TP, Noakes M, Buckley JD, Wittert GA, Yancy WS, Brinkworth GD. Effects of an energy-restricted low-carbohydrate, high unsaturated fat/low saturated fat diet versus a high-carbohydrate, low-fat diet in type 2 diabetes: A 2-year randomized clinical trial. Diabetes Obes Metab 2018;20:858-71. [DOI: 10.1111/dom.13164] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 13.6] [Reference Citation Analysis]
297 Chen AH, Tseng CH. The role of triglyceride in cardiovascular disease in asian patients with type 2 diabetes--a systematic review. Rev Diabet Stud 2013;10:101-9. [PMID: 24380086 DOI: 10.1900/RDS.2013.10.101] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
298 Tomkin GH, Owens D. Diabetes and dyslipidemia: characterizing lipoprotein metabolism. Diabetes Metab Syndr Obes 2017;10:333-43. [PMID: 28814891 DOI: 10.2147/DMSO.S115855] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
299 Fonseca L, Paredes S, Ramos H, Oliveira JC, Palma I. Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol. Lipids Health Dis 2020;19:127. [PMID: 32505210 DOI: 10.1186/s12944-020-01292-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
300 Shi WR, Wang HY, Chen S, Guo XF, Li Z, Sun YX. Estimate of prevalent diabetes from cardiometabolic index in general Chinese population: a community-based study. Lipids Health Dis 2018;17:236. [PMID: 30314516 DOI: 10.1186/s12944-018-0886-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
301 Imam MU, Ismail M, Omar AR, Ithnin H. The hypocholesterolemic effect of germinated brown rice involves the upregulation of the apolipoprotein A1 and low-density lipoprotein receptor genes. J Diabetes Res 2013;2013:134694. [PMID: 23671850 DOI: 10.1155/2013/134694] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
302 Mondol D, Islam MN, Biswas S, Jodder P, Sana S, Saleh MA, Islam MR. Investigation of the synergistic effect of glimepiride and rosuvastatin on alloxan-induced diabetic rat. J Diabetes Metab Disord 2020;19:1415-22. [PMID: 33553033 DOI: 10.1007/s40200-020-00662-6] [Reference Citation Analysis]
303 Ranasinghe P, Wathurapatha WS, Ishara MH, Jayawardana R, Galappatthy P, Katulanda P, Constantine GR. Effects of Zinc supplementation on serum lipids: a systematic review and meta-analysis. Nutr Metab (Lond) 2015;12:26. [PMID: 26244049 DOI: 10.1186/s12986-015-0023-4] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 10.1] [Reference Citation Analysis]
304 Zaman Huri H, Chai Ling L. Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia. BMC Public Health 2013;13:1192. [PMID: 24341672 DOI: 10.1186/1471-2458-13-1192] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
305 Bandesh K, Prasad G, Giri AK, Kauser Y, Upadhyay M, Basu A, Tandon N, Bharadwaj D; INDICO. Genome-wide association study of blood lipids in Indians confirms universality of established variants. J Hum Genet 2019;64:573-87. [PMID: 30911093 DOI: 10.1038/s10038-019-0591-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
306 Ghazali FMM, W Ahmad WMA, Srivastava KC, Shrivastava D, Noor NFM, Akbar NAN, Aleng NA, Alam MK. A Study of Creatinine Level among Patients with Dyslipidemia and Type 2 Diabetes Mellitus using Multilayer Perceptron and Multiple Linear Regression. J Pharm Bioallied Sci 2021;13:S795-800. [PMID: 34447203 DOI: 10.4103/jpbs.JPBS_778_20] [Reference Citation Analysis]
307 Elqadi M, Eweidat K, Abu Sabha M, Yagmour A, Sabarneh A, Nasereddin A, Ereqat S. Methylenetetrahydrofolate reductase C677T gene polymorphism and the association with dyslipidemia in type 2 diabetic Palestinian patients. J Clin Lab Anal 2021;35:e23994. [PMID: 34498771 DOI: 10.1002/jcla.23994] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
308 Heinz-taheny KM, Harlan SM, Qi Z, Heuer JG. Synopsis of Sweet! Mouse Models of Diabetic Kidney Disease. Toxicol Pathol 2018;46:970-5. [DOI: 10.1177/0192623318799995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
309 Villeneuve LM, Natarajan R. The role of epigenetics in the pathology of diabetic complications. Am J Physiol Renal Physiol 2010;299:F14-25. [PMID: 20462972 DOI: 10.1152/ajprenal.00200.2010] [Cited by in Crossref: 204] [Cited by in F6Publishing: 177] [Article Influence: 17.0] [Reference Citation Analysis]
310 Ting RZ, Yang X, Yu LW, Luk AO, Kong AP, Tong PC, So WY, Chan JC, Ma RC. Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study. Cardiovasc Diabetol 2010;9:77. [PMID: 21092182 DOI: 10.1186/1475-2840-9-77] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
311 Chakkarwar VA. Smoking in diabetic nephropathy: sparks in the fuel tank? World J Diabetes 2012; 3(12): 186-195 [PMID: 23301120 DOI: 10.4239/wjd.v3.i12.186] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
312 Khadka M, Todor A, Maner-Smith KM, Colucci JK, Tran V, Gaul DA, Anderson EJ, Natrajan MS, Rouphael N, Mulligan MJ, McDonald CE, Suthar M, Li S, Ortlund EA. The Effect of Anticoagulants, Temperature, and Time on the Human Plasma Metabolome and Lipidome from Healthy Donors as Determined by Liquid Chromatography-Mass Spectrometry. Biomolecules 2019;9:E200. [PMID: 31126114 DOI: 10.3390/biom9050200] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
313 Maulidiani, Abas F, Khatib A, Perumal V, Suppaiah V, Ismail A, Hamid M, Shaari K, Lajis N. Metabolic alteration in obese diabetes rats upon treatment with Centella asiatica extract. Journal of Ethnopharmacology 2016;180:60-9. [DOI: 10.1016/j.jep.2016.01.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
314 Zheng J, Gao Y, Jing Y, Zhou X, Shi Y, Li Y, Wang L, Wang R, Li M, Xiao C, Li Y, Li R. Gender differences in the relationship between plasma lipids and fasting plasma glucose in non-diabetic urban Chinese population: a cross-section study. Front Med 2014;8:477-83. [PMID: 25034241 DOI: 10.1007/s11684-014-0346-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
315 Găman MA, Cozma MA, Dobrică EC, Bacalbașa N, Bratu OG, Diaconu CC. Dyslipidemia: A Trigger for Coronary Heart Disease in Romanian Patients with Diabetes. Metabolites 2020;10:E195. [PMID: 32423050 DOI: 10.3390/metabo10050195] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
316 Tice MJ, Bailey S, Sroga GE, Gallagher EJ, Vashishth D. Non‐Obese MKR Mouse Model of Type 2 Diabetes Reveals Skeletal Alterations in Mineralization and Material Properties. JBMR Plus. [DOI: 10.1002/jbm4.10583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
317 Alam MA, Uddin R, Subhan N, Rahman MM, Jain P, Reza HM. Beneficial role of bitter melon supplementation in obesity and related complications in metabolic syndrome. J Lipids 2015;2015:496169. [PMID: 25650336 DOI: 10.1155/2015/496169] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 5.9] [Reference Citation Analysis]
318 Braun KV, Voortman T, Dhana K, Troup J, Bramer WM, Troup J, Chowdhury R, Dehghan A, Muka T, Franco OH. The role of DNA methylation in dyslipidaemia: A systematic review. Progress in Lipid Research 2016;64:178-91. [DOI: 10.1016/j.plipres.2016.10.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
319 Joseph JT, Ganjifrockwala F, George G. Serum oxidized LDL and the factors associated with LDL oxidation in black South African type 2 diabetes mellitus patients. Int J Diabetes Dev Ctries 2018;38:75-9. [DOI: 10.1007/s13410-017-0559-0] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
320 Karandrea S, Yin H, Liang X, Slitt AL, Heart EA. Thymoquinone ameliorates diabetic phenotype in Diet-Induced Obesity mice via activation of SIRT-1-dependent pathways. PLoS One 2017;12:e0185374. [PMID: 28950020 DOI: 10.1371/journal.pone.0185374] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
321 Nakhjavani M, Morteza A, Esteghamati A, Khalilzadeh O, Zandieh A, Safari R. Serum lipoprotein(a) levels are greater in female than male patients with type-2 diabetes. Lipids 2011;46:349-56. [PMID: 21153771 DOI: 10.1007/s11745-010-3513-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
322 Song E, Koo MJ, Noh E, Hwang SY, Park MJ, Kim JA, Roh E, Choi KM, Baik SH, Cho GJ, Yoo HJ. Risk of Diabetes in Patients with Long-Standing Graves' Disease: A Longitudinal Study. Endocrinol Metab (Seoul) 2021. [PMID: 34915605 DOI: 10.3803/EnM.2021.1251] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
323 Aremu AO, Lilian DC, Olufemi SA, Aderemi OL. Combined but not single treatment with ethinylestradiol/levonorgestrel and spironolactone reduces plasminogen activator inhibitor-1 in insulin-resistant ovariectomised rats. J Renin Angiotensin Aldosterone Syst 2019;20:1470320319895933. [PMID: 31856649 DOI: 10.1177/1470320319895933] [Reference Citation Analysis]
324 Kaul U, Parmar D, Manjunath K, Shah M, Parmar K, Patil KP, Jaiswal A. New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence. Cardiovasc Diabetol 2019;18:80. [PMID: 31208414 DOI: 10.1186/s12933-019-0884-3] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 13.7] [Reference Citation Analysis]
325 Mazumder K, Rabiul Hossain M, Aktar A, Dash R, Farahnaky A. Biofunctionalities of unprocessed and processed flours of Australian lupin cultivars: Antidiabetic and organ protective potential studies. Food Res Int 2021;147:110536. [PMID: 34399513 DOI: 10.1016/j.foodres.2021.110536] [Reference Citation Analysis]
326 Reiter-Brennan C, Cainzos-Achirica M, Soroosh G, Saxon DR, Blaha MJ, Eckel RH. Cardiometabolic medicine - the US perspective on a new subspecialty. Cardiovasc Endocrinol Metab. 2020;9:70-80. [PMID: 32803138 DOI: 10.1097/xce.0000000000000224] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
327 Darroudi S, Saberi-Karimian M, Tayefi M, Arekhi S, Motamedzadeh Torghabeh A, Seyedzadeh Sani SMR, Moohebati M, Heidari-Bakavoli A, Ebrahimi M, Azarpajouh MR, Safarian M, A Ferns G, Esmaeili H, Parizadeh MR, Mokhber N, Mahdizadeh A, Mahmoudi AA, Sahebkar AH, Ghayour-Mobarhan M. Prevalence of combined and noncombined dyslipidemia in an Iranian population. J Clin Lab Anal 2018;32:e22579. [PMID: 29926995 DOI: 10.1002/jcla.22579] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
328 van den Berg SA, Heemskerk MM, Geerling JJ, van Klinken JB, Schaap FG, Bijland S, Berbée JF, van Harmelen VJ, Pronk AC, Schreurs M, Havekes LM, Rensen PC, van Dijk KW. Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake. FASEB J 2013;27:3354-62. [PMID: 23650188 DOI: 10.1096/fj.12-225367] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
329 Abed E, Jarrar Y, Alhawari H, Abdullah S, Zihlif M. The association of cytochrome 7A1 and ATP-binding cassette G8 genotypes with type 2 diabetes among Jordanian patients. Drug Metab Pers Ther 2021. [PMID: 34845882 DOI: 10.1515/dmpt-2021-0164] [Reference Citation Analysis]
330 Shetty SR, Kumar S, Mathur RP, Sharma KH, Jaiswal AD. Observational study to evaluate the safety and efficacy of saroglitazar in Indian diabetic dyslipidemia patients. Indian Heart J 2015;67:23-6. [PMID: 25820046 DOI: 10.1016/j.ihj.2015.02.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
331 Raptis AE, Markakis KP, Mazioti MC, Raptis SA, Dimitriadis GD. What the radiologist needs to know about the diabetic patient. Insights Imaging 2011;2:193-203. [PMID: 22347947 DOI: 10.1007/s13244-011-0068-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
332 Pokharel DR, Khadka D, Sigdel M, Yadav NK, Acharya S, Kafle R, Sapkota RM, Sigdel T. Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes. BMC Res Notes 2017;10:146. [PMID: 28376848 DOI: 10.1186/s13104-017-2465-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
333 Geetha R, Yogalakshmi B, Sreeja S, Bhavani K, Anuradha CV. Troxerutin suppresses lipid abnormalities in the heart of high-fat–high-fructose diet-fed mice. Mol Cell Biochem 2014;387:123-34. [DOI: 10.1007/s11010-013-1877-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
334 Patwardhan VG, Khadilkar AV, Chiplonkar SA, Mughal ZM, Khadilkar VV. Varying relationship between 25-hydroxy-vitamin D, high density lipoprotein cholesterol, and serum 7-dehydrocholesterol reductase with sunlight exposure. Journal of Clinical Lipidology 2015;9:652-7. [DOI: 10.1016/j.jacl.2015.05.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
335 Tavaglione F, Filardi T, Fallarino M, Mandosi E, Turinese I, Rossetti M, Lenzi A, Morano S. The SNP rs9677 of VPAC1 gene is associated with glycolipid control and heart function in female patients with type 2 diabetes: A follow-up study. Nutrition, Metabolism and Cardiovascular Diseases 2016;26:109-13. [DOI: 10.1016/j.numecd.2015.10.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
336 Zhou Y, Deng T, Zhang H, Guan Q, Zhao H, Yu C, Shao S, Zhao M, Xu J. Hypercholesterolaemia increases the risk of high‑turnover osteoporosis in men. Mol Med Rep 2019;19:4603-12. [PMID: 30957178 DOI: 10.3892/mmr.2019.10131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
337 Nepomuceno R, Villela BS, Corbi SC, Bastos AS, Dos Santos RA, Takahashi CS, Orrico SR, Scarel-Caminaga RM. Dyslipidemia rather than Type 2 Diabetes Mellitus or Chronic Periodontitis Affects the Systemic Expression of Pro- and Anti-Inflammatory Genes. Mediators Inflamm 2017;2017:1491405. [PMID: 28316372 DOI: 10.1155/2017/1491405] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
338 Esteghamati A, Asnafi S, Eslamian M, Noshad S, Nakhjavani M. Associations of small dense low-density lipoprotein and adiponectin with complications of type 2 diabetes. Endocrine Research 2014;40:14-9. [DOI: 10.3109/07435800.2014.913614] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
339 Cutler RG, Thompson KW, Camandola S, Mack KT, Mattson MP. Sphingolipid metabolism regulates development and lifespan in Caenorhabditis elegans. Mech Ageing Dev 2014;143-144:9-18. [PMID: 25437839 DOI: 10.1016/j.mad.2014.11.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 5.9] [Reference Citation Analysis]
340 Shim SY, Lee GB, Shim JS, Jung SJ, Kim HC. Association between a family history of diabetes and carotid artery atherosclerosis in Korean adults. Epidemiol Health 2021;43:e2021049. [PMID: 34525777 DOI: 10.4178/epih.e2021049] [Reference Citation Analysis]
341 Luo Y, Qu H, Wang H, Wei H, Wu J, Duan Y, Liu D, Deng H. Plasma Periostin Levels Are Increased in Chinese Subjects with Obesity and Type 2 Diabetes and Are Positively Correlated with Glucose and Lipid Parameters. Mediators Inflamm 2016;2016:6423637. [PMID: 27313402 DOI: 10.1155/2016/6423637] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
342 Wong BX, Kyle RA, Myhill PC, Croft KD, Quinn CM, Jessup W, Yeap BB. Dyslipidemic diabetic serum increases lipid accumulation and expression of stearoyl-CoA desaturase in human macrophages. Lipids 2011;46:931-41. [PMID: 21674150 DOI: 10.1007/s11745-011-3578-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
343 Paladini F, Adinolfi V, Cocco E, Ciociola E, Tamburrano G, Cascino I, Lucantoni F, Morano S, Sorrentino R. Gender-dependent association of type 2 diabetes with the vasoactive intestinal peptide receptor 1. Gene 2012;493:278-81. [PMID: 22166542 DOI: 10.1016/j.gene.2011.11.055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
344 Faisal Lutfi M, Abdel-Moneim AH, Alsharidah AS, Mobark MA, Abdellatif AAH, Saleem IY, Al Rugaie O, Mohany KM, Alsharidah M. Thymoquinone Lowers Blood Glucose and Reduces Oxidative Stress in a Rat Model of Diabetes. Molecules 2021;26:2348. [PMID: 33920728 DOI: 10.3390/molecules26082348] [Reference Citation Analysis]
345 Feng YM, Zhao D, Zhang N, Yu CG, Zhang Q, Thijs L, Staessen JA. Insulin Resistance in Relation to Lipids and Inflammation in Type-2 Diabetic Patients and Non-Diabetic People. PLoS One. 2016;11:e0153171. [PMID: 27073920 DOI: 10.1371/journal.pone.0153171] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
346 Kunz J. [Update on diabetic macroangiopathy]. Pathologe 2012;33:192-204. [PMID: 22576595 DOI: 10.1007/s00292-011-1554-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
347 Shukla K, Dikshit P, Tyagi MK, Shukla R, Gambhir JK. Ameliorative effect of Withania coagulans on dyslipidemia and oxidative stress in nicotinamide-streptozotocin induced diabetes mellitus. Food Chem Toxicol 2012;50:3595-9. [PMID: 22842119 DOI: 10.1016/j.fct.2012.07.026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
348 Shimada A, Kimura H, Oida K, Kanehara H, Bando Y, Sakamoto S, Wakasugi T, Saga T, Ito Y, Kamiyama K, Mikami D, Iwano M, Hirano T, Yoshida H. Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association. Lipids Health Dis 2016;15:57. [PMID: 26984517 DOI: 10.1186/s12944-016-0223-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
349 Feghaly JJ, Mooradian AD. The Rise and Fall "ing" of the HDL Hypothesis. Drugs 2020;80:353-62. [PMID: 32020556 DOI: 10.1007/s40265-020-01265-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
350 Sarfraz M, Sajid S, Ashraf MA. Prevalence and pattern of dyslipidemia in hyperglycemic patients and its associated factors among Pakistani population. Saudi J Biol Sci 2016;23:761-6. [PMID: 27872574 DOI: 10.1016/j.sjbs.2016.03.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
351 Chen SC, Tseng CH. Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients. Rev Diabet Stud. 2013;10:88-100. [PMID: 24380085 DOI: 10.1900/rds.2013.10.88] [Cited by in Crossref: 52] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
352 Mondal S, Kundu B, Saha S. Yoga as a Therapeutic Intervention for the Management of Type 2 Diabetes Mellitus. Int J Yoga 2018;11:129-38. [PMID: 29755222 DOI: 10.4103/ijoy.IJOY_74_16] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
353 Cohen G, Riahi Y, Sasson S. Free Radicals and Metabolic Disorders. In: Chatgilialoglu C, Studer A, editors. Encyclopedia of Radicals in Chemistry, Biology and Materials. Chichester: John Wiley & Sons, Ltd; 2012. [DOI: 10.1002/9781119953678.rad057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
354 Abu-Farha M, Al-Khairi I, Cherian P, Chandy B, Sriraman D, Alhubail A, Al-Refaei F, AlTerki A, Abubaker J. Increased ANGPTL3, 4 and ANGPTL8/betatrophin expression levels in obesity and T2D. Lipids Health Dis 2016;15:181. [PMID: 27733177 DOI: 10.1186/s12944-016-0337-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
355 Nakamura I, Maegawa H, Tobe K, Uno S. Real-World Evidence for Long-Term Safety and Effectiveness of Ipragliflozin in Japanese Patients with Type 2 Diabetes Mellitus: final Results of a 3-Year Post-Marketing Surveillance Study (STELLA-LONG TERM). Expert Opin Pharmacother 2021;22:373-87. [PMID: 33012212 DOI: 10.1080/14656566.2020.1817388] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
356 Gunathilaka TL, Samarakoon K, Ranasinghe P, Peiris LDC. Antidiabetic Potential of Marine Brown Algae-a Mini Review. J Diabetes Res 2020;2020:1230218. [PMID: 32377517 DOI: 10.1155/2020/1230218] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
357 Mullins AP, Arjmandi BH. Health Benefits of Plant-Based Nutrition: Focus on Beans in Cardiometabolic Diseases. Nutrients 2021;13:519. [PMID: 33562498 DOI: 10.3390/nu13020519] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
358 Min HK, Kim SH, Choi JH, Choi K, Kim HR, Lee SH. Impacts of statin and metformin on neuropathy in patients with type 2 diabetes mellitus: Korean Health Insurance data. World J Clin Cases 2021; 9(33): 10198-10207 [PMID: 34904090 DOI: 10.12998/wjcc.v9.i33.10198] [Reference Citation Analysis]
359 Nankar RP, Doble M. Hybrid drug combination: Anti-diabetic treatment of type 2 diabetic Wistar rats with combination of ellagic acid and pioglitazone. Phytomedicine 2017;37:4-9. [DOI: 10.1016/j.phymed.2017.10.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
360 Amigó N, Fuertes-Martín R, Malo AI, Plana N, Ibarretxe D, Girona J, Correig X, Masana L. Glycoprotein Profile Measured by a 1H-Nuclear Magnetic Resonance Based on Approach in Patients with Diabetes: A New Robust Method to Assess Inflammation. Life (Basel) 2021;11:1407. [PMID: 34947938 DOI: 10.3390/life11121407] [Reference Citation Analysis]
361 Tajik B, Voutilainen A, Kauhanen J, Mazidi M, Lip GYH, Tuomainen TP, Isanejad M. Lipid profile, lipid ratios, apolipoproteins, and risk of cardiometabolic multimorbidity in men: The Kuopio Ischaemic Heart Disease Risk Factor Study. Lipids 2022. [PMID: 35049039 DOI: 10.1002/lipd.12337] [Reference Citation Analysis]
362 Bardini G, Rotella CM, Giannini S. Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro- and macrovascular complications. Rev Diabet Stud 2012;9:82-93. [PMID: 23403704 DOI: 10.1900/RDS.2012.9.82] [Cited by in Crossref: 65] [Cited by in F6Publishing: 45] [Article Influence: 6.5] [Reference Citation Analysis]
363 Lemieux S, Bédard A, Piché M, John Weisnagel S, Corneau L, Bergeron J. Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes: Visceral fat and CVD risk in postmenopausal women. Clinical Endocrinology 2011;74:340-5. [DOI: 10.1111/j.1365-2265.2010.03933.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
364 El-shemi AG, Kensara OA, Alsaegh A, Mukhtar MH. Pharmacotherapy with Thymoquinone Improved Pancreatic β-Cell Integrity and Functional Activity, Enhanced Islets Revascularization, and Alleviated Metabolic and Hepato-Renal Disturbances in Streptozotocin-Induced Diabetes in Rats. Pharmacology 2017;101:9-21. [DOI: 10.1159/000480018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
365 Hussain A, Ali I, Kaleem WA, Yasmeen F. Correlation between Body Mass Index and Lipid Profile in patients with Type 2 Diabetes attending a tertiary care hospital in Peshawar. Pak J Med Sci 2019;35:591-7. [PMID: 31258559 DOI: 10.12669/pjms.35.3.7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
366 Olatunji LA, Adeyanju OA, Michael OS, Usman TO, Tostes RC, Soladoye AO. Ameliorative effect of low-dose spironolactone on obesity and insulin resistance is through replenishment of estrogen in ovariectomized rats. Can J Physiol Pharmacol 2019;97:65-74. [PMID: 30422674 DOI: 10.1139/cjpp-2018-0416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
367 McKay GJ, Savage DA, Patterson CC, Lewis G, McKnight AJ, Maxwell AP; Warren 3/UK GoKinD Study Group. Association analysis of dyslipidemia-related genes in diabetic nephropathy. PLoS One 2013;8:e58472. [PMID: 23555584 DOI: 10.1371/journal.pone.0058472] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
368 Hang D, Zeleznik OA, He X, Guasch-Ferre M, Jiang X, Li J, Liang L, Eliassen AH, Clish CB, Chan AT, Hu Z, Shen H, Wilson KM, Mucci LA, Sun Q, Hu FB, Willett WC, Giovannucci EL, Song M. Metabolomic Signatures of Long-term Coffee Consumption and Risk of Type 2 Diabetes in Women. Diabetes Care 2020;43:2588-96. [PMID: 32788283 DOI: 10.2337/dc20-0800] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
369 Abutair AS, Naser IA, Hamed AT. The Effect of Soluble Fiber Supplementation on Metabolic Syndrome Profile among Newly Diagnosed Type 2 Diabetes Patients. Clin Nutr Res 2018;7:31-9. [PMID: 29423387 DOI: 10.7762/cnr.2018.7.1.31] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
370 Zhou J, Deng Z, Lu J, Li H, Zhang X, Peng Y, Mo Y, Bao Y, Jia W. Differential therapeutic effects of nateglinide and acarbose on fasting and postprandial lipid profiles: a randomized trial. Diabetes Technol Ther 2015;17:229-34. [PMID: 25781235 DOI: 10.1089/dia.2014.0299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
371 Vílchez JA, Martínez-Ruiz A, Sancho-Rodríguez N, Martínez-Hernández P, Noguera-Velasco JA. The real role of prediagnostic high-density lipoprotein cholesterol and the cancer risk: a concise review. Eur J Clin Invest 2014;44:103-14. [PMID: 24111547 DOI: 10.1111/eci.12185] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
372 Hedén Ståhl C, Lind M, Svensson AM, Kosiborod M, Gudbjörnsdottir S, Pivodic A, Clements M, Rosengren A. Long-term excess risk of stroke in people with Type 2 diabetes in Sweden according to blood pressure level: a population-based case-control study. Diabet Med 2017;34:522-30. [PMID: 27885698 DOI: 10.1111/dme.13292] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
373 Batty MJ, Chabrier G, Sheridan A, Gage MC. Metabolic Hormones Modulate Macrophage Inflammatory Responses. Cancers (Basel) 2021;13:4661. [PMID: 34572888 DOI: 10.3390/cancers13184661] [Reference Citation Analysis]
374 Osman WM, Jelinek HF, Tay GK, Khandoker AH, Khalaf K, Almahmeed W, Hassan MH, Alsafar HS. Clinical and genetic associations of renal function and diabetic kidney disease in the United Arab Emirates: a cross-sectional study. BMJ Open 2018;8:e020759. [PMID: 30552240 DOI: 10.1136/bmjopen-2017-020759] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
375 Habte ML, Melka DS, Degef M, Menon MKC, Yifter H, Feyisa TO. Comparison of Lipid Profile, Liver Enzymes, Creatine Kinase and Lactate Dehydrogenase Among Type II Diabetes Mellitus Patients on Statin Therapy. Diabetes Metab Syndr Obes 2020;13:763-73. [PMID: 32256093 DOI: 10.2147/DMSO.S234382] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
376 Ayyasamy R, Leelavinothan P. Myrtenal alleviates hyperglycaemia, hyperlipidaemia and improves pancreatic insulin level in STZ-induced diabetic rats. Pharmaceutical Biology 2016;54:2521-7. [DOI: 10.3109/13880209.2016.1168852] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
377 Wu H, Bertrand KA, Choi AL, Hu FB, Laden F, Grandjean P, Sun Q. Persistent organic pollutants and type 2 diabetes: a prospective analysis in the nurses' health study and meta-analysis. Environ Health Perspect 2013;121:153-61. [PMID: 23131992 DOI: 10.1289/ehp.1205248] [Cited by in Crossref: 108] [Cited by in F6Publishing: 102] [Article Influence: 10.8] [Reference Citation Analysis]
378 Tawfik SH, Haiba MM, Saad MI, Abdelkhalek TM, Hanafi MY, Kamel MA. Intrauterine diabetic milieu instigates dysregulated adipocytokines production in F1 offspring. J Anim Sci Technol 2017;59:1. [PMID: 28078101 DOI: 10.1186/s40781-016-0125-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
379 Bertrand C, Saulnier PJ, Potier L, Croyal M, Blanchard V, Gand E, Ragot S, Schneider F, Bocock O, Baillet-Blanco L, Velho G, Marre M, Roussel R, Rigalleau V, Hadjadj S, Mohammedi K; SURDIAGENE Study Group. Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study. Diabetologia 2021;64:668-80. [PMID: 33409569 DOI: 10.1007/s00125-020-05326-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
380 Cha SA, Park YM, Yun JS, Lim TS, Song KH, Yoo KD, Ahn YB, Ko SH. A comparison of effects of DPP-4 inhibitor and SGLT2 inhibitor on lipid profile in patients with type 2 diabetes. Lipids Health Dis 2017;16:58. [PMID: 28403877 DOI: 10.1186/s12944-017-0443-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 7.2] [Reference Citation Analysis]
381 Jelinek HF, Osman WM, Khandoker AH, Khalaf K, Lee S, Almahmeed W, Alsafar HS. Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from United Arab Emirates. BMJ Open Diabetes Res Care 2017;5:e000427. [PMID: 28878941 DOI: 10.1136/bmjdrc-2017-000427] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
382 S G R, Choudhry AA, Gururaja A, Prabhu K. Correlation of Plasma Lipid Profile with Salivary Oxidative Stress Markers in Type II Diabetes Mellitus Patients. J Clin Diagn Res 2014;8:CC08-10. [PMID: 25120974 DOI: 10.7860/JCDR/2014/8233.4451] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
383 Wong BX, Kyle RA, Croft KD, Quinn CM, Jessup W, Yeap BB. Modulation of macrophage fatty acid content and composition by exposure to dyslipidemic serum in vitro. Lipids 2011;46:371-80. [PMID: 21286835 DOI: 10.1007/s11745-011-3528-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
384 Conlon JM, Mechkarska M, Abdel-wahab YH, Flatt PR. Peptides from frog skin with potential for development into agents for Type 2 diabetes therapy. Peptides 2018;100:275-81. [DOI: 10.1016/j.peptides.2017.09.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
385 Haskins IN, Corcelles R, Froylich D, Boules M, Hag A, Burguera B, Schauer PR, Kroh M, Brethauer SA. Primary Inadequate Weight Loss After Roux-en-Y Gastric Bypass Is not Associated with Poor Cardiovascular or Metabolic Outcomes: Experience from a Single Institution. OBES SURG 2017;27:676-80. [DOI: 10.1007/s11695-016-2328-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
386 Wakabayashi I, Daimon T. The "cardiometabolic index" as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clin Chim Acta 2015;438:274-8. [PMID: 25199852 DOI: 10.1016/j.cca.2014.08.042] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
387 Palygin O, Spires D, Levchenko V, Bohovyk R, Fedoriuk M, Klemens CA, Sykes O, Bukowy JD, Cowley AW Jr, Lazar J, Ilatovskaya DV, Staruschenko A. Progression of diabetic kidney disease in T2DN rats. Am J Physiol Renal Physiol 2019;317:F1450-61. [PMID: 31566426 DOI: 10.1152/ajprenal.00246.2019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
388 Mayasari DS, Taufiq N, Hariawan H. Association of monocyte-to-high density lipoprotein ratio with arterial stiffness in patients with diabetes. BMC Cardiovasc Disord 2021;21:362. [PMID: 34330221 DOI: 10.1186/s12872-021-02180-6] [Reference Citation Analysis]
389 Lacerda DDS, Santos CF, Oliveira AS, Zimmermann R, Schneider R, Agostini F, Dani C, Funchal C, Gomez R. Antioxidant and hepatoprotective effects of an organic grapevine leaf (Vitis labrusca L.) extract in diabetic rats. RSC Adv 2014;4:52611-9. [DOI: 10.1039/c4ra08396b] [Cited by in Crossref: 6] [Article Influence: 0.8] [Reference Citation Analysis]
390 Bartelt A, Merkel M, Heeren J. A new, powerful player in lipoprotein metabolism: brown adipose tissue. J Mol Med (Berl) 2012;90:887-93. [PMID: 22231746 DOI: 10.1007/s00109-012-0858-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
391 Potu RB, Lu H, Adeola O, Ajuwon KM. Metabolic markers in Ossabaw pigs fed high fat diets enriched in regular or low α-linolenic acid soy oil. Nutr Metab (Lond) 2013;10:27. [PMID: 23497195 DOI: 10.1186/1743-7075-10-27] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
392 Kowluru RA, Mishra M, Kowluru A, Kumar B. Hyperlipidemia and the development of diabetic retinopathy: Comparison between type 1 and type 2 animal models. Metabolism 2016;65:1570-81. [PMID: 27621192 DOI: 10.1016/j.metabol.2016.07.012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
393 Sonnenburg JL, Bäckhed F. Diet-microbiota interactions as moderators of human metabolism. Nature 2016;535:56-64. [PMID: 27383980 DOI: 10.1038/nature18846] [Cited by in Crossref: 902] [Cited by in F6Publishing: 781] [Article Influence: 150.3] [Reference Citation Analysis]
394 Elnaem MH, Mohamed MHN, Huri HZ, Azarisman SM, Elkalmi RM. Statin Therapy Prescribing for Patients with Type 2 Diabetes Mellitus: A Review of Current Evidence and Challenges. J Pharm Bioallied Sci 2017;9:80-7. [PMID: 28717329 DOI: 10.4103/jpbs.JPBS_30_17] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
395 Son JW, Kim DJ, Lee CB, Oh S, Song KH, Jung CH, Mok JO, Kim JH, Moon MK, Choi KM, Cho JH, Choi SH, Kim SK, Park KS, Kim HS, Kim IJ, Kim YI, Kim HJ, Kim SY, Kim S. Effects of patient-tailored atorvastatin therapy on ameliorating the levels of atherogenic lipids and inflammation beyond lowering low-density lipoprotein cholesterol in patients with type 2 diabetes. J Diabetes Investig 2013;4:466-74. [PMID: 24843697 DOI: 10.1111/jdi.12074] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
396 Cagli K, Tok D, Turak O, Gunertem E, Yayla C, Lafci G, Ulas MM, Cagli K. Monocyte count-to-high-density lipoprotein-cholesterol ratio is associated with abdominal aortic aneurysm size. Biomark Med 2016;10:1039-47. [PMID: 27626503 DOI: 10.2217/bmm-2016-0157] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
397 Zhang C, Gao F, Luo H, Zhang CT, Zhang R. Differential response in levels of high-density lipoprotein cholesterol to one-year metformin treatment in prediabetic patients by race/ethnicity. Cardiovasc Diabetol. 2015;14:79. [PMID: 26068179 DOI: 10.1186/s12933-015-0240-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
398 Ijaz A, Babar S, Sarwar S, Shahid SU, Shabana. The combined role of allelic variants of IRS-1 and IRS-2 genes in susceptibility to type2 diabetes in the Punjabi Pakistani subjects. Diabetol Metab Syndr 2019;11:64. [PMID: 31404179 DOI: 10.1186/s13098-019-0459-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
399 Tian N, Wang J, Wang P, Song X, Yang M, Kong L. NMR-based metabonomic study of Chinese medicine Gegen Qinlian Decoction as an effective treatment for type 2 diabetes in rats. Metabolomics 2013;9:1228-42. [DOI: 10.1007/s11306-013-0535-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
400 Klancic T, Woodward L, Hofmann SM, Fisher EA. High density lipoprotein and metabolic disease: Potential benefits of restoring its functional properties. Mol Metab 2016;5:321-7. [PMID: 27110484 DOI: 10.1016/j.molmet.2016.03.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
401 Mazón-ramos P, Cordero A, González-juanatey JR, Bertomeu Martínez V, Delgado E, Vitale G, Fernández-anaya S. Control de factores de riesgo cardiovascular en pacientes diabéticos revascularizados: un subanálisis del estudio ICP-Bypass. Revista Española de Cardiología 2015;68:115-20. [DOI: 10.1016/j.recesp.2014.03.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
402 Komurcu-Bayrak E, Onat A, Yuzbasiogullari B, Mononen N, Laaksonen R, Kähönen M, Hergenc G, Lehtimäki T, Erginel-Unaltuna N. The APOE -219G/T and +113G/C polymorphisms affect insulin resistance among Turks. Metabolism 2011;60:655-63. [PMID: 20723945 DOI: 10.1016/j.metabol.2010.06.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
403 Gao F, Luo H, Fu Z, Zhang CT, Zhang R. Exome sequencing identifies novel ApoB loss-of-function mutations causing hypobetalipoproteinemia in type 1 diabetes. Acta Diabetol 2015;52:531-7. [PMID: 25430706 DOI: 10.1007/s00592-014-0687-7] [Reference Citation Analysis]
404 Bailey SD, Xie C, Paré G, Montpetit A, Mohan V, Yusuf S, Gerstein H, Engert JC, Anand SS; EpiDREAM and INTERHEART Investigators. Variation at the DPP4 locus influences apolipoprotein B levels in South Asians and exhibits heterogeneity in Europeans related to BMI. Diabetologia 2014;57:738-45. [PMID: 24362726 DOI: 10.1007/s00125-013-3142-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
405 Chang CT, Yang CY, Tsai FJ, Lin SY, Chen CJ. Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease. Biomed Res Int 2015;2015:164846. [PMID: 26090384 DOI: 10.1155/2015/164846] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
406 Halcox J, Misra A. Type 2 diabetes mellitus, metabolic syndrome, and mixed dyslipidemia: how similar, how different, and how to treat? Metab Syndr Relat Disord 2015;13:1-21. [PMID: 25402738 DOI: 10.1089/met.2014.0049] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
407 Ergen HA, Zeybek U, Gök O, Karaali ZE. Investigation of ABCA1 C69T polymorphism in patients with type 2 diabetes mellitus. Biochem Med (Zagreb) 2012;22:114-20. [PMID: 22384526 DOI: 10.11613/bm.2012.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
408 Shen XL, Liu H, Xiang H, Qin XM, Du GH, Tian JS. Combining biochemical with (1)H NMR-based metabolomics approach unravels the antidiabetic activity of genipin and its possible mechanism. J Pharm Biomed Anal 2016;129:80-9. [PMID: 27411170 DOI: 10.1016/j.jpba.2016.06.041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
409 Khadke S, Harke S, Ghadge A, Kulkarni O, Bhalerao S, Diwan A, Pankaj M, Kuvalekar A. Association of Fasting Plasma Glucose and Serum Lipids in Type 2 Diabetics. Indian J Pharm Sci 2015;77:630-4. [PMID: 26798181 DOI: 10.4103/0250-474x.169033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
410 Zeng M, Liang Y, Li H, Wang B, Chen X. A metabolic profiling strategy for biomarker screening by GC-MS combined with multivariate resolution method and Monte Carlo PLS-DA. Anal Methods 2011;3:438-45. [DOI: 10.1039/c0ay00518e] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
411 Gok O, Karaali ZE, Acar L, Kilic U, Ergen A. ABCG5 and ABCG8 gene polymorphisms in type 2 diabetes mellitus in the Turkish population. Can J Diabetes 2015;39:405-10. [PMID: 26088706 DOI: 10.1016/j.jcjd.2015.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
412 Ribeiro Hde S, Anastácio LR, Ferreira LG, Lagares EB, Lima AS, Correia MI. Prevalence and factors associated with dyslipidemia after liver transplantation. Rev Assoc Med Bras (1992) 2014;60:365-72. [PMID: 25211421 DOI: 10.1590/1806-9282.60.04.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
413 Sanchis P, Rivera R, Berga F, Fortuny R, Adrover M, Costa-Bauza A, Grases F, Masmiquel L. Phytate Decreases Formation of Advanced Glycation End-Products in Patients with Type II Diabetes: Randomized Crossover Trial. Sci Rep 2018;8:9619. [PMID: 29941991 DOI: 10.1038/s41598-018-27853-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
414 Moss AS, Dimitropoulos G, Connolly DL, Lip GYH. Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus. Expert Opin Pharmacother 2017;18:1101-14. [PMID: 28669216 DOI: 10.1080/14656566.2017.1350647] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
415 Ito S, Hosaka T, Yano W, Itou T, Yasumura M, Shimizu Y, Kobayashi H, Nakagawa T, Inoue K, Tanabe S, Kondo T, Ishida H. Metabolic effects of Tofogliflozin are efficiently enhanced with appropriate dietary carbohydrate ratio and are distinct from carbohydrate restriction. Physiol Rep 2018;6. [PMID: 29520981 DOI: 10.14814/phy2.13642] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]